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ABSTRACT
The biocompatibility of chitosan and its similarity with glycosaminoglycans
make it attractive for cartilage engineering despite its limited cell adhesion properties.
Structural and chemical characteristics of chitosan scaffolds may be improved for
cartilage engineering application. We planned to evaluate chitosan meshes produced by
a novel replica molding technique and the effect of chitosan structure on mesenchymal
stem cells chondrogenesis. Another objective was to improve cell adhesion and
chondrogenesis on chitosan by modifying the chemical composition of the scaffold
(reacetylation, collagen II or hyaluronic acid coating).
A replica molding technique was developed to produce chitosan meshes of
different fiber-width. A polyglycolic acid mesh served as a reference. Constructs were
analyzed at two and 21 days after seeding chondrocytes with confocal microscopy,
scanning electron microscopy, histology and quantitative analysis (weights, DNA,
glycosaminoglycans and collagen II). Chondrocytes maintained their phenotypic
appearance and a high viability but attached preferentially to polyglycolic acid. Matrix
production per chondrocyte was superior on chitosan.
Chitosan meshes and sponges were analyzed after seeding and culture of
mesenchymal stem cells under chondrogenic condition for 21 days. The cellularity was
similar between groups but matrix production was greater in fibrous constructs.
Chitosan and reacetylated-chitosan scaffolds were coated with collagen II or
hyaluronic acid. Scaffolds were characterized prior to seeding mesenchymal stem cells.
Chitosan meshes were then coated with collagen at two densities. Polyglycolic acid
served as a reference. Constructs were evaluated after seeding or culture of
mesenchymal stem cells for 21 days in chondrogenic medium. Mesenchymal stem cells
adhered less to reacetylated-chitosan despite collagen coating. Hyaluronic acid did not
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affect cell adhesion. The cell attachment on chitosan correlated with collagen density.
The cell number and matrix production were improved after culture in collagen coated
meshes.
The differences between polyglycolic acid and chitosan are likely to result from
the chemical composition. Chondrogenesis is superior on chitosan meshes compared to
sponges. Collagen II coating is an efficient way to overcome the poor cell adhesion
properties of chitosan. These findings encourage the use of chitosan meshes coated
with collagen II and confirm the importance of biomimetic scaffolds for tissue
engineering. The decreased cell adhesion on reacetylated chitosan and the poor
mechanical stability of polyglycolic acid limit their use for tissue engineering.
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1CHAPTER 1: INTRODUCTION
Cartilage disease is a leading cause of lameness and loss of function in human
and animals. Tissue engineering offers new strategies for treating damaged or diseased
cartilage, where cells are allowed to proliferate and organize their extracellular matrix
in a three-dimensional lattice to form ex vivo a clinically functional tissue. Chitosan is a
natural aminopolysaccharide with a superior biocompatibility attributed to its structural
similarity with glycosaminoglycans naturally present in the extracellular matrix of
cartilage. A great deal of research has recently focused on chitosan for its use as a
biomaterial in a number of biomedical applications and more specifically in the field of
cartilage tissue engineering. In fact, chitosan is mechanically strong, biodegradable,
biocompatible, and it can be molded as porous structures of various geometries and
forms. However, its chemical composition limits cell adhesion and its structural
characteristics have not been evaluated for cartilage tissue engineering applications.
Chitosan scaffolds do not fulfill all criteria necessary for cartilage tissue engineering
and further modifications are necessary before their clinical application.
The long-term goal of this research is to modify the structural characteristics
and the chemical composition of chitosan scaffolds in order to improve cartilage tissue
engineering application with chitosan scaffolds. Our first objective is to produce non-
woven pure chitosan scaffolds with fibers of different widths using a novel replica
molding technique, and to evaluate their use for cartilage tissue engineering. Our
second objective is to ameliorate the microstructure of chitosan scaffolds to obtain
constructs with better chondrogenic differentiation of mesenchymal stem cells. Our last
objective is to improve cell adhesion on chitosan scaffolds by modification of the
degree of deacetylation of chitosan and/or type II collagen coating or hyaluronic acid
2coating to overcome their decreased cell adhesion and improve the resulting
characteristics of the engineered constructs.
3CHAPTER 2: LITERATURE REVIEW
2.1. Structure and Physiology of Articular Cartilage
Articular cartilage is the specialized organ covering the ends of diarthrodial
joints. It is tough, resilient, and structured to undergo years of cyclic loading without
breaking down. Cartilage is only 2 to 3 mm thick in humans or even less in small
animals (less than 2 mm in dogs)(Frisbie et al, 2006), but it can support one to 9.36
megapascals of force an average of two million times each year (Silva et al, 2002;
Yoshida et al, 2006). Articular cartilage varies in thickness, cell density, and
mechanical properties within the same joint, among joints, and among species;
however, in all synovial joints, cartilage has the same general structure and
components, and performs the same functions (Athanasiou et al, 1991). An
understanding of the structure and physiology of articular cartilage is essential for the
development of a repair technique. In fact, both restorative techniques and cartilage
tissue engineering aim at the restitution of the cartilage physiology by replicating its
structure and composition. Articular cartilage consists of cells, water, and an
extracellular matrix (ECM) (Ewing et al, 1990). Matrix composition and structural
orientation allow articular cartilage to convert shear and compression forces into tensile
forces at the bone surface.
Chondrocytes are distinguished from other cells by a spheroid shape and the
synthesis of type II collagen, large aggregating proteoglycans, and specific non-
collagenous proteins. Uninjured adult articular cartilage has no vascular supply and the
cells exchange gas and nutrients by way of diffusion through a double barrier (synovial
fluid and cartilage matrix) (Buckwalter et al, 1997). This perfusion of the matrix and
4chondrocytes occurs from movement of the synovial fluid that occurs with the loading
and unloading that accompanies joint motion. Because of the small pore size in the
superficial zone (around 50 angstroms), it may take ten seconds to several hours for
molecular diffusion into the cartilage to occur, depending on the structure, size, charge,
and weight of the molecule (Wallis et al, 1987). The nature of this system leaves
chondrocytes with a low concentration of oxygen relative to most other tissues. The
total metabolic activity of the tissue is low because of the low cell density (cells make
up only about five percent of the wet weight of cartilage) despite chondrocytes being
surprisingly active metabolically. After completion of skeletal growth, most
chondrocytes stop dividing but continue to synthesize collagens, proteoglycans, and
non-collagenous proteins. This continued synthetic activity suggests that maintenance
of articular cartilage requires substantial ongoing internal remodeling of the
macromolecular framework of the matrix.
The matrix of the articular cartilage consists of two components that give the
tissue its form and stability: the tissue fluid (65 to 80% of the wet weight) and the
framework of structural macromolecules (20 to 35% of the wet weight). The
interactions between the tissue fluid and the macromolecular framework give the tissue
its mechanical properties of stiffness and resilience (Ewing et al, 1990; Maroudas et al,
1987). Three classes of macromolecules are present within the tissue but differ in their
concentrations and contributions to the tissue properties. Collagens contribute for more
than 60% of the dry weight of cartilage, proteoglycans for 25 to 30% of the dry weight,
and non-collagenous proteins and glycoproteins for 10 to 20% of the dry weight.
Articular cartilage contains two major classes of proteoglycans: large aggregating
proteoglycan monomers or aggrecans and small proteoglycans including decorin,
biglycan, and fibromodulin (Poole et al, 1996; Roughley, 2006). The large aggregating
5proteoglycans help maintaining the fluid within the matrix. Proteoglycans consist of a
protein core with one or more hydrophilic glycosaminoglycans (GAG) chains. The
GAG consists of unbranched polysaccharides with negatively charged carboxylate or
sulfate groups that attract cations, hence water. GAG found in cartilage include
hyaluronic acid (HA), chondroitin sulfate, keratan sulfate, heparan sulfate, and
dermatan sulfate. Aggrecans have large numbers of chondroitin-sulfate and keratan-
sulfate chains attached to the protein core filament. Most aggrecans associate non-
covalently with HA and small non-collagenous proteins to form proteoglycan
aggregates. The formation of aggregates helps to anchor proteoglycans within the
matrix, preventing their displacement during deformation of the tissue. Proteoglycans
retain water within the matrix of cartilage, therefore playing a crucial role in the creep
and stress relaxation of cartilage loaded in compression. The pressurization of the fluid
phase contributes to more than 90% of the load transmission function of cartilage. The
collagen network resists the osmotic pressure caused by the inorganic ions associated
with the proteoglycans and provides the tensile stress of the tissue (Moskowitz, 2001).
Under stress, fluid moves in and out of tissue and mechanical properties change with
fluid movement establishing both the stiffness and the viscoelastic properties of
cartilage. Viscoelasticity describes materials that exhibit time dependent strain.
Articular cartilage is also anisotropic, which means that the intrinsic material properties
depend on the matrix orientation and composition, as well as the direction in which the
cartilage is loaded. Collagen fibrils are distributed relatively uniformly throughout the
depth of the cartilage, except for the collagen-rich superficial zone. The collagen
fibrillar meshwork gives cartilage its form and tensile strength (Moskowitz, 2001).
Articular cartilage contains multiple genetically distinct collagen types, specifically
types II, VI, IX, X, and XI. Types II, IX, and XI form the cross-banded fibrils seen with
6electron microscopy. The organization of these fibrils into a tight meshwork that
extends throughout the tissue provides the tensile stiffness and strength of articular
cartilage and contributes to the cohesiveness of the tissue by entrapping the large
proteoglycans. The principal collagen, type II collagen, makes up more than 90% of the
total collagen content of hyaline cartilage (Hollander et al, 1994; Mayne, 1989). Type
II collagen is composed of three identical collagen fibers that form a triple helix and is
assembled outside the cell in a staggered fashion. Its diameter ranges from 140 to 500
nm (Fertala et al, 1996; Shoulders et al, 2009). The non-collagenous proteins organize
and stabilize the macromolecular framework of the matrix, while others help
chondrocytes bind to the macromolecules of the matrix. In general, they consist
primarily of proteins and have a few attached monosaccharides and oligosaccharides.
Anchorin CII, a collagen-binding chondrocyte surface protein, may help anchoring
chondrocytes to the collagen fibrils of the matrix. Cartilage oligomeric protein, an
acidic protein, is concentrated primarily within the territorial matrix of the chondrocyte
and binds to chondrocytes. This molecule may have value as a marker of cartilage
turnover and of progression of cartilage degeneration in patients affected by
osteoarthritis. The functions of fibronectin and tenascin in articular cartilage remain
poorly understood, but they may have roles in matrix organization and cell-matrix
interactions.
The concentration of molecules and cells varies among sites within articular
cartilage and also with age, injury to the cartilage, and disease. The morphological
changes from the articular surface to the subchondral bone make possible to layer adult
cartilage into superficial, transitional (or middle), deep (or radial), and calcified zones.
The matrix differs with respect to concentrations of water, proteoglycan, and collagen;
and with respect to the size of the aggregates (Ewing et al, 1990). Cells in different
7zones differ not only in shape, size, and orientation relative to the articular surface, but
also in metabolic activity. Each of these zones has a specific physiologic response to
force (Cole et al, 2004). The superficial zone has the highest cell density, where
chondrocytes are small and flattened with their long axis parallel to the surface. Cells in
the transitional zone assume a spheroidal shape and synthesize a matrix that has larger-
diameter collagen fibrils, a higher concentration of proteoglycan, and lower
concentrations of water and collagen compared to the superficial zone. In the deep
zone, the cells are larger and arranged with their long axes perpendicular to the surface.
The cellular arrangement throughout the different zone is complementary to the
organization of the collagen fibrils. Fibril alignment has a tangential orientation in the
superficial layer and an orientation perpendicular to the articular surface in the deeper
layers. The superficial layer can therefore withstand tension in the plane of the articular
surface. In contrast, the fibrils in the middle and deep zones are organized to provide
increased resilience to compressive forces. The collagen fibrils are more concentrated
at the surface of the cartilage, whereas the concentration of proteoglycans is increasing
with increasing depth from the cartilage surface (Todhunter et al, 2003).
The interdependence of the chondrocytes and the extracellular matrix
contributes to the maintenance of articular cartilage throughout life. The main functions
of the chondrocytes are the synthesis and degradation of matrix macromolecules.
Enzymes produced by chondrocytes are presumably responsible for degradation of the
matrix macromolecules, and chondrocytes respond to the presence of fragmented
matrix molecules by increasing their synthetic activity to replace the degraded
components of the ECM. The mechanisms that control the balance between these
activities remain poorly understood, but cytokines with catabolic and anabolic effects
appear to have important roles (van der Kraan et al, 2002). For example, interleukin-1
8induces the expression of matrix metalloproteases degrading the macromolecules and
interferes with the synthesis of matrix proteoglycans at the transcriptional level. Other
cytokines, such as insulin-dependent growth factor-I and transforming growth factor-
beta, oppose these catabolic activities by stimulating matrix synthesis and cell
proliferation. In response to a variety of stimuli, these cytokines are synthesized and
released into the matrix, where they bind to receptors on the cell surfaces (autocrine or
paracrine mechanisms) or become trapped within the matrix. The degradative response
are the result of a complex cascade that includes the activation or inhibition of
interleukin-1, stromelysin, aggrecanase, plasmin, and collagenase by factors such as
prostaglandins, transforming growth factor-beta, tumor necrosis factor, tissue inhibitors
of metalloproteases, tissue plasminogen activator, plasminogen activator inhibitor, and
other molecules. The details of how the mechanical loading of joints influences the
function of chondrocytes remain unknown, but deformation of the matrix produces
mechanical, electrical, and physicochemical signals that may have major roles in
stimulating chondrocytes (Gray et al, 1988). Loading may also cause persistent changes
in the molecular organization of the matrix, altering the response of the chondrocytes to
subsequent loading. The capacity of the cells to respond to stimuli decreases with
aging. These age-related changes may limit the ability of the cells to maintain the tissue
and thereby contribute to the degeneration of the articular cartilage.
2.2. Pathophysiology and Repair of Cartilage Defects
The relationship between duration, intensity, and frequency of an applied force
on articular cartilage is described as an envelope of function (Cole et al, 2004; Dye,
1996). The envelope of function of a joint describes a range of energy absorption that is
9compatible with tissue homeostasis of an entire joint system. The upper limit of a given
joint’s envelope of function represents a threshold between homeostatic loading and
excessive loading initiating inflammation and repair. The range of loads sufficient to
activate such a physiologic response, but insufficient to cause macrostructural failure,
can be termed the zone of supraphysiologic overload (Cole et al, 2004; Dye, 1996).
Cartilage defects can be caused by both macrostructural failure and supraphysiologic
overload. In the first stages of cartilage damage, the matrix contains a higher
percentage of the proteoglycans in a nonaggregated form, unbound to HA. This
breakdown of proteoglycan architecture increases the permeability of the matrix. The
increase in water content results in a significant diminution of the hydraulic pressure in
early osteoarthritic cartilage. This causes a reduction in the compressive stiffness of the
tissue, which can be identified clinically as the softening of early chondromalacia.
While collagen content is initially maintained, collagen organization is severely
perturbed. Three collagenases of the matrix metalloproteinase family can cleave the
triple helix of type II collagen. This results in a decrease in the tensile stiffness and
strength provided by the normal three dimensional architecture of the collagen
interfibrillar network. The water content of cartilage increases further as a result of
collagen loss. These events are followed by cell metaplasia and loss. The activity of the
chondrocytes is affected by the mechanical loads, hydrostatic pressures, and soluble
mediators leading to the fibrillation, fissuring, and erosion of cartilage.
The limited potential for chondrocyte proliferation and the avascular nature of
the cartilage tissue all contribute to the poor healing potential of adult cartilage,
eventually leading to osteoarthritis (Tew et al, 2001). Initially small focal lesions, not
necessarily associated with significant clinical problems, usually progress to partial-
thickness chondral injury. The process of destruction advances downward until the
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osseous region is reached leading to full-thickness osteochondral defects, more
commonly symptomatic (Goldring, 2000). Full-thickness chondral defects fill with
blood and quickly organize into a fibrous clot. Undifferentiated bone marrow elements,
blood, and platelets organize in the defect. These cells produce a reparative granulation
tissue which becomes less vascular and more firm. The fibrous tissue undergoes a
progressive hyalinization and chondrification to produce a fibro-cartilaginous tissue.
This fibrocartilage has reduced resilience and stiffness, poor wear characteristics, and a
predilection for deterioration over time.
Osteoarthritis may develop secondary to the progression of an isolated cartilage
defect (Cole et al, 2004; Dye, 1996). Cartilage disease is a leading cause of lameness
and loss of function in human and animals (LeCouteur et al, 2005; Piermattei et al,
2006). According to the Center for Disease Control, one of every three adults in the
United States is affected by osteoarthritis (Helmick et al, 2008). In 2003, the total cost
of arthritis and other rheumatic conditions reached approximately 128 billion dollars in
the United States and has since increased due to demographics in western countries and
advances in geriatric medicine (Centers for Disease Control and Prevention (CDC),
2007; Hootman et al, 2006). The national economic cost of equine lameness has been
estimated between 678 million and one billion dollars in 1998 (Seitzinger et al, 2000).
Lameness due to joint injury and disease is the most prevalent cause of diminished
athletic function and wastage in racing horses (Goodrich et al, 2006; Jeffcott et al,
1982). Osteoarthritis is also estimated to affect as much as 20% of the canine
population over one year of age and 90% of cats over 12 years of age (Hardie et al,
2002; Johnston, 1997). Considerable attention has consequently focused on cartilage
resurfacing techniques in both human and veterinary medicine to treat cartilage defects.
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Reparative strategies for cartilage defects utilize marrow stimulation techniques
to induce formation of fibrocartilage. The premise of bone marrow stimulation
techniques is to attract undifferentiated mesenchymal cells from the underlying bone
marrow, and rely on them and the physiologic vascular response to injury to heal the
full-thickness chondral defect (Cole et al, 2004). Bone marrow stimulation techniques
for the treatment of chondral defects include abrasion arthroplasty, débridement and
drilling, and microfracture. They typically result in a partial filling of the articular
defect with fibrocartilage (primarily type I collagen). This contrasts with the desired
hyaline cartilage that is mainly type II collagen produced by the chondrocytes. In terms
of articular cartilage repair, this tissue has reduced mechanical properties and
deteriorates over time. Varying amounts of fibrous tissue, fibrocartilage tissue, and
articular cartilage-like tissue filling the defects have been reported after marrow
penetrating techniques. Proponents of these techniques advocate their technical
simplicity, low patient morbidity, and cost effectiveness. However, clinical
improvement obtained from these procedures is usually short lived since the repair
tissue generated is largely fibrous in nature with poor durability (Cole et al, 2004).
Restorative treatments attempt to replace damaged cartilage with hyaline or
hyaline-like tissue using osteochondral or chondrocyte transplantation (Lewis et al,
2006). The rationale behind osteochondral transfer is to replace the damaged cartilage-
bone unit with healthy tissue obtained from a non weight bearing area. The technique
consists in preparation of the chondral lesion, creation of the recipient socket(s) and
graft(s) harvest followed by delivery of the graft(s) (Cole et al, 2004). Autologous
chondrocyte transplantation involves collection of cartilage from the patient, in vitro
expansion, and reimplantation in a full-thickness articular surface defect (Grande et al,
1989). Both resurfacing procedures have their limitations. They require the harvest of
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normal cartilage or osteochondral graft from a non-weight bearing region with the risk
of donor site morbidity (Barnewitz et al, 2006; Bartlett et al, 2005; Lewis et al, 2006).
The final tissue obtained with both techniques does not have the exact same properties
of the surrounding cartilage. Osteochondral transfer can also lead to graft fracture, graft
delamination, and loose bodies. Avascular necrosis must be considered a risk,
particularly if multiple deep plugs are harvested or deposited (Hangody et al, 1997).
Autologous chondrocyte transplantation requires two surgeries and carries the risk of
graft delamination or failure and intra-articular adhesions (Driesang et al, 2000; Lewis
et al, 2006; Peterson et al, 2002). The clinical need for improved options in
reconstructive surgery has motivated research aimed at creating new cartilage in vitro
and in vivo.
2.3. Cartilage Tissue Engineering
Tissue engineering is a rapidly developing field offering new perspectives in
the treatment of damaged cartilage. The basic premise of cartilage tissue engineering
relies on the use of a scaffold to encourage cells to proliferate and organize their ECM
in order to form ex vivo a clinically functional tissue, exhibiting histochemical,
biochemical and biomechanical properties identical to native cartilage. Three key
constituents form the basis of a tissue engineering approach, namely, cells, a scaffold,
and signaling molecules (Athanasiou et al, 2001). Thus, the goal is to encourage cells to
adhere to the three-dimensional (3-D) matrix and form a clinically functional tissue.
However, the cell source, 3-D matrix and culture conditions matching these goals
remain unclear (Chung et al, 2008; Coutts et al, 2001).
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Primary chondrocytes and mesenchymal progenitor cells are the main cell types
used for cartilage tissue engineering applications. Both primary and passaged
chondrocytes have been seeded onto scaffolds and tested for their ability to make
cartilaginous material (Freed et al, 1993). The use of chondrocytes is appealing because
their differentiated phenotype allows the cells to produce an extracellular matrix of
desired properties. However, the use of primary chondrocytes is limited because of the
morbidity associated with over-harvesting cartilage. Thus, serial passage of
chondrocytes as monolayers is a convenient means to acquire a large number of cells
that generally retain the chondrocyte phenotype throughout the first few passages. The
dedifferentiation process affecting chondrocytes cultured on protein monolayers is well
recognized and has prompted the development of 3-D culture techniques for cartilage
engineering and the search of alternative cell sources (Brodkin et al, 2004). The use of
mesenchymal stem cells (MSCs) as a cell source is attractive because they can be
harvested from bone marrow aspirates, adipose, and other tissues with less morbidity
than chondrocytes (Fortier, 2005; Gao et al, 2007; Helder et al, 2007). They have self-
renewal abilities, are immuno-privileged, and can differentiate into several cell types
including chondrocytes (Caplan, 2005; Gao et al, 2007). MSCs, in constrast to
chondrocytes, integrate better into damaged sites according to several studies
(Obradovic et al, 2001; Vunjak-Novakovic, 2002), and repairs by MSCs may last
longer than those in which chondrocytes are used (Hui et al, 2004). However, in one
study, MSCs injected in a fibrin vehicle failed to improve the long-term histologic
appearance or biochemical composition of full-thickness cartilage lesions in horses
(Wilke et al, 2007). These findings may reflect a deficient retention of MSCs after
injection in the lesion or an inability of MSCs to achieve the genetic profile of a fully
differentiated chondrocyte. Research efforts currently focus on improving the
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chondrogenic potential of MSCs in vitro, as well as their delivery in vivo. Two
approaches are possible: a fully-differentiated construct can be implanted within the
defect or only a basic building block can be implanted in vivo to ensure that the
differentiation and remodeling of repair tissue occur under physiological conditions.
Regardless of the approach, delivering cells cultured on biodegradable carriers may
improve their retention within the damaged area (Radice et al, 2000). In addition,
scaffolds provide a novel strategy to modulate the differentiation of cells (Bosnakovski
et al, 2006; Wollenweber et al, 2006).
Cell behavior is affected by the signaling molecules as well as both the
structural characteristic and the chemical composition of the scaffold, ultimately
impacting the performance of tissue-engineered constructs (Athanasiou et al, 2001; Li
et al, 2006; Moroni et al, 2006; Pei et al, 2002). The scaffolds should have several
inherent properties including appropriate mechanical strength, biodegradability,
biocompatibility, a porous structure, and surface characteristics promoting cell
adhesion and proper cell differentiation (Coutts et al, 2001; Freed et al, 1994). The list
of biomaterials tested for cartilage repair is extensive but a scaffold fulfilling those
criteria has yet to be determined (Coutts et al, 2001). Polyglycolic acid (PGA) mesh has
been extensively studied for cartilage tissue engineering but its in vivo application has
been limited due to its low mechanical properties (Goldstein et al, 1999; Griffon et al,
2005; Griffon et al, 2006; Jeon et al, 2007).
2.4. Chitosan Scaffolds for Cartilage Tissue Engineering
The biocompatibility and similarity of chitosan to GAG naturally present in the
ECM of cartilage make it particularly attractive as a candidate for the repair of cartilage
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defects (VandeVord et al, 2002). Chitosan is formed by alkaline deacetylation of chitin,
the second most abundant natural polysaccharide, primarily obtained as a subproduct of
shellfish, such as crabs and shrimps (Chenite et al, 2000). Chitosan is composed of
glucosamine and N-acetyl glucosamine linked in a β(1–4) manner; the glucosamine/N-
acetyl glucosamine ratio being referred as the degree of deacetylation (DD). Depending
on the source and preparation procedure, its molecular weight ranges from 300 to over
1000kD with a degree of deacetylation from 50% to 95%. Chitosan is normally
insoluble in aqueous solutions above pH 7; however, the free amino groups of
glucosamine are protonated in dilute acids (pH < 6.0) which facilitate solubility of the
molecule. Chitosan has been studied for use in a number of biomedical applications
including wound dressings, drug delivery systems, and space filling implants and has
gained Food and Drug Administration approval for human use in wound dressing
(Khor et al, 2003; Madihally et al, 1999). A number of researchers have examined the
host tissue response to chitosan-based implants. These materials evoke a minimal
foreign body reaction, with little or no fibrous encapsulation (Mao et al, 2004;
VandeVord et al, 2002). Considerable attention has recently focused on chitosan-based
materials and their applications in the field of cartilage tissue engineering (Chen et al,
2007; Di Martino et al, 2005; Griffon et al, 2005; Griffon et al, 2006; Jeon et al, 2007;
Kasahara et al, 2008; Madihally et al, 1999; Nettles et al, 2002; Nettles et al, 2002; Suh
et al, 2000; Yamane et al, 2005; Yamane et al, 2006). Chitosan has adequate
mechanical properties for this application (Di Martino et al, 2005; Griffon et al, 2005;
Griffon et al, 2006; Jeon et al, 2007; Kasahara et al, 2008; Madihally et al, 1999;
Nettles et al, 2002; Yamane et al, 2005; Yamane et al, 2006). Lysozyme is the primary
enzyme responsible for in vivo degradation of chitosan through hydrolysis of acetylated
residues. Highly deacetylated forms may last several months in vivo; eventual
16
degradation products being oligosaccharides of variable length. Chitosan is also an
attractive biomaterial as it can be molded as porous structures of various geometries
and forms. However, the chitosan scaffolds used in previous studies do not fulfill all
criteria necessary for cartilage tissue engineering (Coutts et al, 2001). The structural
characteristics and the chemical composition of chitosan scaffolds could therefore be
further modified for cartilage tissue engineering applications.
2.5. Structure of Chitosan Scaffolds
The physical properties of a 3-D scaffold affect cell behavior, ultimately
determining the performance of a tissue-engineered construct (Li et al, 2006; Moroni et
al, 2006). The 3-D structures most commonly used for articular cartilage tissue
engineering application consist of fiber meshes and sponges (Lee et al, 2008;
Raghunath et al, 2007). The scaffold microstructure can guide cellular organization,
cell proliferation, cell differentiation, and matrix production (Chen et al, 2007; Griffon
et al, 2006; Lee et al, 2008; Li et al, 2006; Malda et al, 2005; Raghunath et al, 2007;
Sasmazel et al, 2008; Yamane et al, 2006). However, the principal requirement for the
scaffold is to act as an open mesh to permit cells to permeate its entire structure during
initial attachment and to ensure that nutrients or waste can diffuse in or out as needed.
Previous approaches to produce chitosan scaffolds meeting this requirement for
structural openness include freeze-drying, wet spinning, and electrospinning.
Freeze-drying is a widely accepted method to form a sponge-like structure.
Porous chitosan structures can be formed by freezing and lyophilizing chitosan-acetic
acid solutions in suitable molds. During the freezing process, ice crystals nucleate from
the solution and grow along the lines of thermal gradients. Exclusion of the chitosan
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acetate salt from the ice crystal phase and subsequent ice removal by lyophilization
(water sublimation) generates a porous material whose mean pore size can be
controlled by varying the freezing rate and hence the ice crystal size (Suh et al, 2000).
Increasing the freezing rate will increase the crystal size and therefore the pore size.
However, the growth of crystals along the line of thermal gradient lead to variability in
pore size within each scaffold (Nettles et al, 2002). Finally, the pore diameter of the
resulting scaffolds can only be controlled in the 1 to 250 μm range (Madihally et al,
1999).
Wet spinning has been used to manufacture polymer fibers and has been
adapted to obtain chitosan meshes. The process involves extruding a chitosan solution
through a spinneret into a coagulation bath inducing the precipitation of the chitosan
followed by post-drawing. Solvents are commonly used to guarantee the spinnability of
the chitosan solution. Several interplaying factors, such as coagulation rate, diffusion
rate difference between solvent and coagulant, and coagulation temperatures determine
the morphology of the resultant fibers (Tuzlakoglu et al, 2004). The post-draw allows
to reduce the diameter of the fibers but usually not to less than 10 µm and to diminish
the entanglement. Despite recent advances allowing wet spinning without solvents, its
use for the fabrication of chitosan scaffolds is limited by the minimal diameter of the
fibers obtained and the lack of uniformity of the fibers.
Electrospinning has been adapted to chitosan in an effort to create smaller
diameter fibrous networks. The principle consists in using an electric field to draw a
polymer solution from a spinneret to a collector. A high voltage electric field (10 – 20
kV) is used to generate a surface charge sufficient to overcome the surface tension in a
pendant drop of the polymer fluid (Bhattarai et al, 2005). Several processing
parameters (type of solution, viscosity, surface tension, net charge density, flux in the
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syringe, and ambient parameters) control the electrospinning process, especially the
diameter and morphology of the resulting fibers (Pham et al, 2006). The variability in
constitution inherent to natural products, the poor solubility and the high surface
tension due to the polycationic nature of chitosan complicate the matter, often requiring
various plasticizers and surfactants to be added to the blend. In fact, high electrical
forces are required to produce electrospun fibers of chitosan because of its surface
tension. Moreover, particles are often formed during the electrospinning process, likely
due to the repulsive forces between ionic groups in the chitosan backbone (Lee et al,
2009). The diameters of chitosan fibers produced by electrospinning range from 38
nanometers to few micrometers but most chitosan solution were mixed with
trifluoroacetic acid, glutaraldehyde, polyethylene oxide, or triton X-100 (Bhattarai et al,
2005; Geng et al, 2005; Lee et al, 2009; Schiffman et al, 2007). The biocompatibility of
these solution modifiers must be considered carefully before application of fibrous
product from this process to cell cultures and, further, in vivo implantation. As an
alternative approach to improve its electrospinnability, chitosan can be mixed with
other synthetic or natural polymers such as poly(ethylene oxide), poly(vinyl alcohol),
or poly(lactic acid). These approaches are limited by differences in water solubilities of
the components and also differing biological effects of the hybrid scaffolds compared
to chitosan scaffolds (Bhattarai et al, 2005; Lee et al, 2009). Finally, the high velocities
of the product deposition at the target combined with the softness of the chitosan blend
compress the scaffold, detracting from its openness to cell diffusion. These limitations
justify the search for new methods to produce pure chitosan fibers of a pre-determined
diameter.
Despite the growing interest for chitosan as a biomaterial for tissue engineering,
most studies evaluating pure chitosan scaffolds have focused on sponges (Griffon et al,
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2005; Griffon et al, 2006; Jeon et al, 2007; Nettles et al, 2002; Subramanian et al, 2005;
Suzuki et al, 2008). Fibrous scaffolds may be more appealing than sponges and films
for cartilage tissue engineering as they simulate more closely the fibrous nature of the
native cartilaginous ECM (Moroni et al, 2006). The scaffold microstructure can guide
cellular organization, cell proliferation, and matrix production (Chen et al, 2007;
Griffon et al, 2006; Lee et al, 2008; Li et al, 2006; Malda et al, 2005; Raghunath et al,
2007; Sasmazel et al, 2008; Yamane et al, 2006). More specifically, fiber diameter and
surface topology were found to affect MSCs seeding, proliferation and spreading
(Moroni et al, 2006). The differentiation of stem cell is also affected by the scaffold
structure (Fromstein et al, 2008). Li et al. showed that polycaprolactone fibrous
scaffolds were suitable for supporting chondrogenic induction of human bone marrow-
derived MSCs in vitro (Li et al, 2005). Culturing MSCs on the scaffolds not only
produced comparable quantities of GAGs, but also exhibited similar levels of
chondrogenic gene expression as MSCs cultured as in a cell pellet, an established
model of chondrogenic induction. Culture on fibrous scaffolds did not necessitate the
extremely high cell densities previously shown to be critical for MSC differentiation. A
decreased fiber diameter was found to stimulate chondrocyte proliferation and GAG
production (Li et al, 2006), and enhance the chondrogenic differentiation of
mesenchymal stem cells (Wise et al, 2008). The high surface area–volume ratio and
controlled porous architecture of these meshes also ensures abundant area for cell
attachment and allows for a higher density of cells to be cultured. However, scaffold
evaluation requires the control of the uniformity of fiber diameter and of the chemical
composition to facilitate a rigorous comparison between scaffolds. The influence of
chitosan fibrous matrices in terms of fiber diameter and arrangement on chondrocyte
functions remains poorly characterized. Although chondrogenic differentiation of
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MSCs has been documented on a chitosan copolymer gel, the extent to which the
structural characteristics of chitosan scaffolds modulate the chondrogenic potential of
MSCs remains largely unexplored (Cho et al, 2004).
2.6. Cell Adhesion on Chitosan Scaffolds
Limited adhesion of chondrocytes and MSCs on chitosan compared to other
biomaterials such as PGA has been previously reported by our group (Griffon et al,
2010). Others have confirmed these results which limit the application of chitosan for
tissue engineering (Amaral et al, 2007; Seda Tigli et al, 2007; Wenling et al, 2005). The
initial attachment of cells to a scaffold is a prerequisite for a successful tissue
engineering outcome as it is a decisive factor for cell-matrix interactions (Mahmood et
al, 2004). Improving cell attachment and cell distribution on chitosan-based scaffolds is
therefore essential for cultivation of clinically relevant constructs. The ideal seeding
criteria on 3-D scaffolds have been described as: (i) a high yield (or percentage of
seeded cells attaching to the matrix) to optimize the use of donor cells, (ii) a high
kinetic rate, to minimize the time during which shear-sensitive cells will be suspended
freely in the medium, and (iii) a spatially uniform attachment of cells throughout the
matrix, to provide a basis for uniform tissue generation (Vunjak-Novakovic et al,
1998).
The influence of the DD of chitosan on cell attachment remains controversial
and varies between reports and cell types (Fakhry et al, 2004). In several studies,
deacetylation increased the attachment of fibroblasts, Schwann cells, keratinocytes, and
neurons to chitosan films or sponges (Amaral et al, 2007; Chatelet et al, 2001; Freier et
al, 2005; Seda Tigli et al, 2007; Tigli et al, 2008; Wenling et al, 2005). However, in
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others, a lower DD of chitosan improved chondrogenesis without affecting the
attachment of chondrocytes, fibroblasts, or osteoblasts (Hamilton et al, 2006; Kuo et al,
2006; Suphasiriroj et al, 2009; Suzuki et al, 2008). The extent to which reacetylation of
chitosan could improve MSCs seeding for cartilage tissue engineering remains unclear.
Besides the reduction of nonspecific protein adsorption by molecular
modification of the biomaterial itself, the strategy most commonly employed to
improve cell adhesion on biomaterials focuses on immobilization of adhesion
molecules to ensure controlled interaction between the cells and the scaffold (Carvalho
et al, 2008). The effect of specific molecules on cell adhesion is dependent on the
chemical modification, the bulk biomaterial, and the type of cells evaluated (Wang et
al, 2003). The molecular candidate should ideally not only improve cell attachment but
also promote proper cell differentiation.
2.7. Chemical Modifications of Chitosan
Chemical modifications can be useful to improve cell adhesion but also to
modulate cell signaling in order to influence cell differentiation. The biomaterial used
for cartilage tissue engineering should have several inherent properties including
appropriate mechanical strength, biodegradability, biocompatibility, and surface
characteristics promoting cell adhesion and proper cell differentiation (Coutts et al,
2001; Freed et al, 1994). Clearly, it is not realistic to expect that any one material will
fulfill the entire list of requirements for cartilage tissue engineering. However, it is
possible to combine different types of material and adjust the chemical composition
and the properties of the scaffold (Ameer et al, 2002). The particular benefits of hybrid
scaffolds result from the combined effects of the different polymers on cell seeding,
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proliferation, differentiation, and structural support. The combination of chitosan with
other biomaterials can have synergetic effects on cell adhesion, the principal drawback
of chitosan (Griffon et al, 2010), and on cell differentiation and extracellular matrix
formation. Few chitosan-based scaffolds have previously been described.
Iwasaki et al. reported on an alginate-based chitosan hybrid mesh, which increased cell
attachment and proliferation in vitro compared to alginate scaffold (Iwasaki et al,
2004). The tensile strength of these hybrid scaffolds was also increased but the overall
seeding yield was still low. Chitosan has been combined with poly(l-lactic acid); the
modified substrate showed increased cell adhesion, proliferation and biosynthetic
activity compared to poly(l-lactic acid) (Cui et al, 2003). Hsu et al. developed chitosan-
alginate-hyaluronic acid complexes with or without covalent attachment of arginine-
glycine-aspartic acid (RGD) containing protein to increase the cellular attachment on
chitosan (Hsu et al, 2004). Scaffolds were seeded with chondrocytes and cartilage was
observed one month after in vivo implantation both in presence or absence of RGD
indicating potential of this composite material for cartilage regeneration. However, the
mechanical stability of those scaffolds was limited. Chitosan-based scaffolds can also
be used to deliver growth factors in a controlled fashion to promote the ingrowth and
biosynthetic ability of chondrocytes. Lee et al. reported porous type I collagen-
chitosan-GAG scaffolds loaded with TGF-β1 (Lee et al, 2004). This scaffold exhibited
controlled release of TGF- β 1 and promoted cartilage regeneration. Moreover, addition
of chitosan to the type I collagen scaffold was done to improve the mechanical
properties and stability of the collagen network by inhibiting the action of collagenases
(Lee et al, 2004; Taravel et al, 1996). The functionalization of chitosan by
incorporating other proteins is therefore a promising approach to improving its
performance in articular cartilage repair (Lee et al, 2002). Different molecules have the
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potential to increase cell adhesion on chitosan. The molecule used should not only
improve cell attachment but also promote proper cell differentiation.
The peptide RGD is the coating agent most often used to promote the
attachment of cells on material surfaces (Hersel et al, 2003; Hubbell, 1995). However,
RGD was found to inhibit fibroblast adhesion and proliferation on reacetylated chitosan
films (Carvalho et al, 2008). Moreover, it was found to limit chondrogenesis of MSCs
(Carvalho et al, 2008; Connelly et al, 2007).
Type II collagen is another candidate which could improve cell attachment via
interactions with the integrins, the discoidin-domain receptors, and the annexin V
receptors (Durr et al, 1993; Freyria et al, 2009; Gigout et al, 2008; Reid et al, 2000).
Type II collagen differs from type I collagen in structure, distribution, and effects on
cells (Duan et al, 2007; Kim et al, 2010). Type I collagen can be found in skeletal tissue
but also in skin, cornea, arteries, internal organs, and granulation tissues; whereas the
natural distribution of type II collagen is more specific to skeletal tissues (hyaline
cartilage and bone growth plate). Although type I collagen coating has been found to
improve cell adhesion on chitosan, the use of type II collagen is more attractive as a
biomimetic strategy to improve both MSCs adhesion and chondrogenic differentiation
as it simulates more closely the nature of the native cartilaginous ECM (Lutolf et al,
2005; Moroni et al, 2006; Stevens et al, 2005). Type II collagen has been shown to
improve chondrogenesis through integrin interactions which modulate the transforming
growth factor (TGF) signaling cascade involving Smad 2 and Smad 3 (Schneiderbauer
et al, 2004). Type II collagen has been used as a bulk biomaterial in few tissue
engineering applications (Chang et al, 2010; Hsu et al, 2006; Pieper et al, 2002; Tsai et
al, 2002; Yen et al, 2009). Scaffolds composed of bulk type II collagen-poly-
caprolactone improved chondrocytes adhesion and proliferation compared to poly-
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caprolactone scaffolds (Chang et al, 2010). In one study, chondrocyte proliferation and
distribution were improved in type II collagen matrices compared to type I collagen
matrices (Pieper et al, 2002). Although the mechanical properties and dimensional
stability of type II collagen prevent its use as a bulk biomaterial, they do not affect its
potential as a coating molecule for scaffolds used in skeletal tissue engineering (Hsu et
al, 2006). To our knowledge, the evaluation of type II collagen coating has only been
limited to one study on poly-lactide-coglycolide scaffolds (Hsu et al, 2006).
Hyaluronic acid is another candidate which could improve cell attachment via a
CD44-mediated recruitment of cells (Herrera et al, 2007). Fast and early cell-HA
interactions tether cells to the surface, providing the temporal and spatial framework for
slower integrin-mediated interactions to occur (Cohen et al, 2006; Peniche et al, 2007;
Tan et al, 2007; Yamane et al, 2005; Zaidel-Bar et al, 2004; Zimmerman et al, 2002).
HA seems particularly promising in cartilage tissue engineering applications since it
has been an important mainstay of the clinical arsenal against joint disease for decades.
The use of intra-articular injection of HA to reduce lameness has been supported by
several clinical studies (Asheim et al, 1976; Frisbie et al, 2009; Rose, 1979).
Experimentally, intra-articular injection of HA has been shown to improve weight
bearing after radiocarpal bone osteochondral fracture as determined by force plate
analysis and to preserve articular cartilage integrity as determined by histopathologic
analysis (Auer et al, 1980; Frisbie et al, 2009; Gingerich et al, 1981). Results of clinical
studies in horses and humans indicate that high molecular weight HA has better clinical
efficacy than low molecular weight HA (Atamaz et al, 2006; Philips, 1989). In cartilage
tissue engineering, HA was found to improve cell adhesion and proliferation on
chitosan fibrous sheets (Yamane et al, 2005). However, the effect of the HA coating on
cell distribution was not evaluated.
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2.8. Objectives and Hypotheses
The long-term goal of this research is to modify the structural characteristics
and the chemical composition of chitosan scaffolds in order to improve their
application in cartilage tissue engineering.
We plan to accomplish the overall objective of this application by pursuing the
following specific aims:
(1) To produce non-woven chitosan scaffolds composed of fibers of 4, 13, and
22 µm in width using a novel replica molding technique, and to evaluate adhesion,
proliferation, and the synthesis of the ECM by chondrocytes cultured on these chitosan
fibrous scaffolds compared to PGA mesh with fibers of 13 µm in diameter.
We hypothesized that chitosan and PGA scaffolds of similar fiber diameter would
result in constructs of similar properties. We also hypothesized that decreasing the fiber
width of chitosan would improve the characteristics of the extracellular matrix.
(2) To compare MSCs chondrogenesis on chitosan sponges and meshes.
We hypothesized that chitosan fibrous scaffolds would stimulate chondrogenesis of
MSCs compared to chitosan sponges.
(3) To determine the extent to which reacetylation of chitosan and/or type II
collagen coating or HA coating could improve MSCs seeding.
We hypothesized that MSCs adhesion would be greater on chitosan meshes compared
to reacetylated chitosan meshes, that type II collagen coating would improve cell
seeding efficiency on both chitosan and reacetylated chitosan scaffolds, and that
hyaluronic acid would improve cell seeding on chitosan scaffolds.
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(4) To produce chitosan fibrous scaffolds coated with different densities of type
II collagen and to evaluate the effect of this coating on MSCs seeding and
chondrogenesis.
We hypothesized that coating chitosan meshes with type II collagen would improve
MSCs adhesion and chondrogenesis.
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CHAPTER 3: METHODOLOGY AND RESULTS
Unless otherwise specified, the reagents were obtained from Sigma (Sigma, St. Louis,
MO, USA).1
3.1. Cartilage Tissue Engineering on Fibrous Chitosan Scaffolds Produced by a Replica
Molding Technique
3.1.1. Materials and Methods
3.1.1.1. Scaffolds:
The chitosan (“Chito Clear” fg95, Primex, Iceland) used in this study has a
molecular weight of about 500 kDA, a degree of deacetylation greater than 95 % and a
viscosity of 500 cP at 1% concentration. Three types of non-woven fibrous scaffolds
1 The materials of this thesis have been previously published in:
- Ragetly GR, Slavik GJ, Cunningham BT, Schaeffer DJ, Griffon DJ: Cartilage tissue
engineering on fibrous chitosan scaffolds produced by a replica molding technique. J.
Biomed. Mater. Res. A. 93:46–55, 2010
- Ragetly GR, Griffon DJ, Lee HB, Fredericks LP, Gordon-Evans WG, Chung YS:
Effect of chitosan scaffold microstructure on mesenchymal stem cells chondrogenesis.
Acta Biomaterialia. 6(4):1430-6, 2010
- Ragetly GR, Griffon DJ, Lee HB, Chung YS. Effect of collagen II coating on
mesenchymal stem cell adhesion on chitosan and on reacetylated chitosan fibrous
scaffolds. Journal of Material Sciences: Material in Medicine. 2010, May 25. Epub
ahead of print.
- Ragetly GR, Griffon DJ, Chung YS. The effect of type II collagen coating of chitosan
fibrous scaffolds on mesenchymal stem cell adhesion and chondrogenesis. Acta
Biomaterialia. 2010, May 22. Epub ahead of print.
The copyright owners have provided permission to reprint.
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were prepared using a replica molding technique (Slavik et al, 2007). A 3 % chitosan
solution in 0.2 M acetic acid was filtered (0.45 µm and 0.2 µm pore nylon membrane
syringe filter) and poured into an array of microchannels recessed into a molded surface
of polydimethylsiloxane (Figure 1A). The mold was inverted into a pool of coagulant
solution consisting of 0.150M NaOH / 0.150M Na2SO4 ([Na+] = 0.450M, pH = 13.0
accounting for ionic activity corrections) in deionized water at 40°C for 45 minutes.
Released fibers were allowed to soak in the coagulant bath for 24 hours. The
dimensions and shape of the channels in the master template were defined by a
standard photolithographic process followed by anisotropic reactive ion etching of the
underlying silicon wafer. Replica castings of this silicon wafer surface in elastomeric
polydimethylsiloxane served as the mold for chitosan. Three types of scaffolds were
produced with fibers varying in width: 1- Chi 22: 22 ± 4 µm (n = 24) 2- Chi 13: 13 ± 3
µm (n = 24), 3- Chi 4: 4.7 ± 1.6 µm (n = 24) (Figure 1 B-D). The fiber size was
evaluated by scanning electron microscopy (SEM) by random measurements and
confirmed using calibrated optical microscopy while still in the medium.
Our reference group consisted of a PGA mesh previously tested for in-vitro
chondrogenesis (n = 24) (Synthecon Inc., Houston, TX) (Griffon et al, 2005; Griffon et
al, 2006; Seddighi et al, 2008). This non-woven mesh is made of 13 m-diameter fibers
with a void volume of 97%.
All scaffolds were standardized to a dry weight of 2.0 ± 0.1 mg. They were
sterilized with ethylene oxide gas and rehydrated through successive passage in
phosphate buffered saline (PBS) and culture medium solutions (Marreco et al, 2004).
The culture medium consisted of Dulbecco’s modified Eagle’s medium (DMEM)
containing 4.5 g.L-1 glucose, 10 % Fetal Bovine Serum (FBS, ATCC, Manassas, VA,
USA), 584 mg.L-1 glutamine, 100 U.mL-1 penicillin, 100 g.mL-1 streptomycin, 10 mM
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Figure 1: Fabrication of novel random fibrous chitosan scaffolds. A: Schematic
illustration of the micromolding process. B-D: SEM micrographs of chitosan scaffolds
composed of fibers measuring 22 µm (B), 13 µm (C), and 4 µm (D) in width.
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N-2-hydroxyethylpiperazineN’-2-ethanesulfonic acid (HEPES), 0.1 mM nonessential
amino acids, 0.4 mM proline, 50 g.mL-1 ascorbic acid and 25 g.mL-1 amphotericin B
(Griffon et al, 2006).
3.1.1.2. Chondrocytes:
Cartilage was aseptically collected from both stifles of four four-week-old pigs.
NIH guidelines for the care and use of laboratory animals have been observed and all
procedures in this study were approved by the Institutional Animal Care and Use
Committee of the University of Illinois. Cartilage was obtained from weight bearing
and non-weight bearing surfaces of the femoral condyles and tibial plateau. Cartilage
was then minced in 1 mm3 cubes, rinsed in PBS with 2 % penicillin-streptomycin, prior
to overnight digestion in culture medium and 0.15 % collagenase type II (Worthington,
Freehold, NJ) (Griffon et al, 2006). Cells from two pigs were pooled together in each
experiment to decrease individual variability. Cell number and viability were evaluated
via trypan blue exclusion using a haemocytometer. For each experiment, samples of
cells were placed in a six-well plate to evaluate cell attachment under monolayer
culture. Samples of pooled fresh cells were also used to determine the DNA content per
cell. A cell suspension containing 2.5x106 cells in 150 μL of medium was dropped on
the surface of each scaffold (12 of each per experiment: PGA, Chi 22, Chi 13 and Chi
4) and allowed to incubate at 37˚C for one hour. After one hour the procedure was
repeated and 0.5 ml of medium was added prior to incubation for two hours. Scaffolds
seeded with a total of 5x106 chondrocytes were transferred to untreated six-well non-
tissue culture plates and placed on a platform shaker oscillating at 100 rpm. The
constructs were maintained in culture medium for 48 hours or 21 days. The culture
medium was changed three times a week.
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3.1.1.3. Evaluation of Constructs:
Seeding was evaluated at 48 hours in 24 constructs via SEM, DNA, water and
GAG quantifications. Chondrogenesis was evaluated after 21 days of culture in 72
constructs via SEM, live/dead assay, histology, DNA, water, GAG and type II collagen
quantifications.
Live/dead assay
The viability of chondrocytes in the constructs was determined using a
live/dead assay kit (Molecular Probes, Carlsbad, CA), where calcein AM labels viable
cells (green fluorescence) and ethidium homodimer 1 labels dead cells (red
fluorescence) according to the manufacturer’s protocol. Briefly, constructs were
washed three times in sterile PBS for two minutes, and sectioned perpendicularly into
1.5 mm–thick slices using a parallel razor blade. Slices from the periphery and centre
of each construct were placed on a glass slide and immersed in 200 μL of PBS solution
containing 2 mM calcein AM and 4 mM ethidium homodimer 1 reagents prior to
incubation for 40 min at 37ºC. Constructs were observed via confocal microscopy
(Olympus BX50 Confocal Microscope, Center Valley, PA) using Melles Griot Argon
and Krypton lasers at excitation wavelengths of 488 nm and 568 nm. The intensities of
viable and dead cells were recorded on four slides at a magnification of 40 x and two
slides at a magnification of 10 x (Figure 2 A-D). The slides were analyzed using the
Fluoview software (Olympus) to determine the ratio between viable and dead cells
Figure 2 E).
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Figure 2: Live/dead assay of a chitosan construct. A: Argon laser allows identification
of live cells. B: Same field: Krypton laser allows identification of dead cells. C: Same
field without laser. D: Same field with combined Argon and Krypton allowing
visualization of both live and dead cells for analysis. E: Intensity ratio from the
corresponding field obtained by computer analysis.
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Scanning electron microscopy
Constructs were fixed in a 2.5 % gluteraldehyde solution (Electron Microscopy
Sciences, Hatfield, PA) with sodium cacodylate buffer for two hours. After rinsing with
buffer, they were submerged in 1 % osmium tetroxide (Electron Microscopy Sciences)
in 0.1 M sodium cacodylate for 90 minutes. Following a buffer rinse, the constructs
were dehydrated through an ethanol series. Finally, constructs were placed in
hexamethyldisilazane (Electron Microscopy Sciences) for 45 minutes and left under a
fume hood until completely dry. Each construct was bisected in order to evaluate the
surfaces as well as the central section of the construct. A total of two samples
(superficial and centre) were mounted for each construct and sputter coated with gold –
palladium prior to examination with SEM (Hitachi S4700, Schaumburg, IL) at 1.0 kV.
Criteria evaluated included cell morphology, size, attachment to the support and
presence of cytoplasmic extensions. Cells contained in 115x80 µm fields acquired at
five superficial and five central positions within the constructs were counted (Griffon et
al, 2005; Griffon et al, 2006).
Histopathology
The constructs were fixed in 10% neutral buffered formalin, embedded in
plastic and cut via microtome to produce 1 µm-thick sections (Seddighi et al, 2008).
Sections were stained with Safranin O Green or Toluidine Blue O using a technique
previously described and were examined to evaluate cell and construct morphology and
the presence of matrix and remnants of scaffold (Getzy et al; Grogan et al, 2006).
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Water, DNA, and GAG contents
Scaffolds were weighed before and after dehydration to determine their wet and
dry weights, respectively. The water content was subsequently calculated as:
Water content (%) = (Weight wet – Weight dry) x 100% / Weight wet
Samples were digested in papain for 16 hours at 60C and assayed for GAG
content via spectrophotometry with 1,9 dimethylmethylene blue chloride (Farndale et
al, 1986). Shark chondroitin sulfate (5 to 50 μg.mL-1) was used as a standard (Griffon et
al, 2006). The same papain digestion technique was used for a fluorometric assay of
DNA with Hoechst 33258 (Kim et al, 1988). The cell seeding efficiency was calculated
48 hours after seeding as a ratio between the number of cells attached and the number
of cells seeded on each scaffold. The number of cells attached was obtained using the
average DNA content per chondrocyte estimated previously by our group (5.87 pg per
cell) (Griffon et al, 2005). The change in dry weight was calculated and expressed as a
percentage.
Type II collagen content
Type II collagen content was determined by enzyme linked immunosorbent
assay (Arthrogen-CIA® Native Type II Collagen Detection Kit, Chondrex, Redmond,
WA) after digestion of the constructs in pepsin and elastase (Griffon et al, 2006).
Collagen fibrils were solubilised with pepsin and further digested with pancreatic
elastase. The optical density of the reacted collagen with monoclonal antibody was read
at 490 nm (Seddighi et al, 2008).
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3.1.1.4. Statistical Analysis
DNA, water contents, GAG, GAG/DNA ratio, Type II collagen/DNA ratio;
viability of the chondrocytes (%), cell counts via SEM and increase in dry weight (%)
were compared between groups with a risk factor of less than 0.05 considered
statistically significant. All data were expressed as mean ± standard deviation.
Statistical differences were evaluated with a one-way analysis of variance and Tukey’s
highly significant differences test using Systat 11.0 statistical software (Wilkinson,
Chicago, IL).
3.1.2. Results
The initial viability of chondrocytes isolated in this study and determined by
trypan blue was greater than 95 %.
3.1.2.1. Seeding Control:
Scanning Electron Microscopy
Polyglycolic acid constructs contained more cells than any of the chitosan
constructs. All cells seeded on chitosan scaffolds had the size and rounded appearance
of normal chondrocytes (Figure 3, Figure 4 AC). Most cells seeded on the PGA
scaffolds had the phenotypic appearance of normal chondrocytes. However, isolated
cells tended to be stellate in shape, with prominent cytoplasmic extensions. The cells
tended to be grouped in chondrones rather than being uniformly distributed on the
surface of chitosan scaffolds. This heterogeneity resulted in a wide variation in cell
number per field on scanning electron microscopy of chitosan constructs.
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Figure 3: Scanning electron microscopy micrograph of a Chi 4 construct 48 hours after
seeding chondrocytes (Magnification 6000x). The chondrocyte attached to the fiber
exhibits a rounded shape and has the size of a normal chondrocyte.
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Figure 4: Scanning electron microscopy of constructs seeded with chondrocytes. A:
PGA mesh, 48 hours after seeding. B: PGA, 21 days after seeding. C: Chi 4, 48 hours
after seeding. D: Chi 4, 21 days after seeding. E: Center of a Chi 4 construct, 21 days
after seeding. Cells are embedded in abundant extracellular matrix (100x). F: High
magnification SEM of a Chi 13 construct, 21 days after seeding. Note the rounded
appearance of cells and their relationship to adjacent ECM (800x).
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DNA quantification confirmed SEM findings. At 48 hours after seeding, the
quantity of total DNA yield per mg wet weight was 0.10 ± 0.04 μg.mg-1 for Chi 4, 0.18
± 0.02 μg.mg-1 for Chi 13, 0.16 ± 0.01 μg.mg-1 for Chi 22, 0.47 ± 0.09 μg.mg-1 for
PGA. The PGA mesh contained more DNA than chitosan constructs (p < 0.001).
Chitosan constructs composed of larger fibers (22 or 13 µm) contained more DNA than
those made of 4 µm-width fibers (p = 0.02 and p = 0.05, respectively). The cell seeding
efficiency after 48 hours of culture was 48.8% for Chi 4, 70.2% for Chi 13, 65.7% for
Chi 22, and 121.4% for PGA.
3.1.2.2. Evaluation of the Constructs after twenty-one Days:
Cell viability
The viability of the chondrocytes estimated by the live/dead assay did not differ
between the four groups and was above 80 % for all scaffold types.
Scanning electron microscopy
Chondrocytes tended to form a film covering the surface of each construct and
were embedded in ECM (Figure 4 BDEF). The amount of ECM observed in chitosan
constructs appeared to correlate inversely with the width of fibers, more matrix being
noted on 4 µm-width fibers. This group consisted essentially of a uniform matrix into
which cells were embedded (Figure 4 EF). Cell counts were higher for PGA and Chi 22
than Chi 13 and Chi 4 constructs (Table 1). Whereas the chitosan scaffolds appeared
intact, few remnants of PGA fibers were identified.
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Table 1: Water content, SEM and biochemical analysis of PGA and chitosan constructs
(Mean ± Standard Deviation) 21 days after seeding. a, b: groups with different letters
differ statistically (p < 0.05)
40
Histopathology
No major differences were found between the two histological stains (Figure 5
AB). Positive intensities were consistent with the presence of GAG surrounding cells in
all groups (Figure 5 ABDE). In these areas, cell density was low with moderate
distance between cells. These cells exhibited the size and rounded appearance
characteristic of normal chondrocytes. This appearance may correspond to a more
hyaline-like matrix formed in chitosan constructs (Figure 5 AC). As for the SEM
evaluation, the chitosan scaffolds appeared intact, whereas few remnants of PGA fibers
were identified on histological sections.
Cell number
PGA constructs contained more DNA than any other groups. The only
statistical difference between chitosan groups was found between Chi 4 containing
more DNA than Chi 22 (Table 1).
Quantitative evaluation of the extracellular matrix
The water content did not differ between groups (Table 1). The percentage of
increase in dry weight was lowest in the PGA group and greatest in Chi 4 (Table 1).
PGA constructs contained more GAG than chitosan constructs (p < 0.001). Within
chitosan constructs, GAG content correlated inversely with fiber-width (Table 1). PGA
constructs achieved a GAG/DNA ratio (19.4 ± 3.1) generally lower than chitosan
constructs (range from 27.3 to 35.8 for the GAG/DNA). This difference was significant
between Chi 22 and PGA (p < 0.001) (Table 1). The type II collagen/DNA ratio in all
chitosan constructs (101.4 to 110.8) was greater than in PGA constructs (7.5 ± 3.5) (p <
0.001) (Table 1).
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Figure 5: Histological analysis of PGA and chitosan constructs after 21 days of culture.
A-B: Histological appearance of the same area of a Chi 13 construct stained with
Toluidine Blue O (A) and Safranin O (B). C: Section of native cartilage stained with
Toluidine Blue O for comparison. D-E: Histological appearance (Toluidine Blue O) of
a PGA construct (D) and a Chi 22 construct (E) (4x).
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3.2. Effect of Chitosan Scaffold Microstructure on Mesenchymal Stem Cells
Chondrogenesis
3.2.1. Materials and methods
3.2.1.1. Scaffolds
The chitosan (Taehoon bio, Korea) had a molecular weight of about 400 kDA, a
degree of deacetylation of 90% and a viscosity of 330 cP at a 0.5% concentration. The
same chitosan solution was used to prepare the two types of scaffold. Chitosan flakes
were dissolved and stirred at room temperature for 48 hours in a 0.2 M solution of
acetic acid to obtain a 2% chitosan solution.
Chitosan fibrous scaffolds (CF, n = 30) were prepared using the wet spinning
method (Figure 6). The chitosan solution was pumped into a 0.1 mm×1,500 holes
spinneret using the geared metering pump. To coagulate the chitosan solution, the
spinneret was immersed in an aqueous spin bath containing 10% sodium hydroxide.
After exiting the coagulation bath, fibers were washed in alternative hot and cold water
baths. Fibers (measuring 13 µm in diameter) were cut and dispersed in water, prior to
filtration with 100 stainless steel mesh and drying. Chitosan fibrous scaffolds were cut
to measure 5 mm in diameter and 3 mm in height.
Chitosan sponge scaffolds (CS, n = 30) were prepared using a freeze-drying
technique (Griffon et al, 2005). The chitosan solution was poured into a 96-well mold,
and cooled at a controlled rate of - 0.3°C.min-1 to – 80°C for 72 hours to obtain a mean
pore size of 120 µm. The resulting solid product was then lyophilized for 48 hours.
Scaffolds had a diameter of 5 mm, and a height of 3 mm.
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Figure 6: Diagram representing the wet spinning apparatus used to produce chitosan
microfibers.
44
All scaffolds were standardized to a dry weight of 3.3 ± 0.3 mg. They were
sterilized with ethylene oxide gas and rehydrated through a series of ethanol/PBS
solutions (100, 95, 75, 50, 0% ethanol) (Marreco et al, 2004). Scaffolds were
subsequently incubated at 37°C on a shaker incubator in DMEM (ATCC) for 24
hours before cell seeding (Griffon et al, 2006).
3.2.1.2. Mesenchymal Stem Cells:
A mesenchymal cell line (D1 ORL UVA, ATCC) derived from a multipotent
mouse bone marrow stromal precursor was used for this study. Complete culture
medium consisted of DMEM containing 4.5g.L-1 glucose, supplemented with 10% fetal
bovine serum (ATCC), 100 U.mL-1 penicillin, and 100 g.mL-1 streptomycin. Cells
were harvested at their fourth passage and resuspended in chondrogenic medium prior
to seeding. Chondrogenic medium consisted of DMEM containing 4.5g.L-1 glucose,
supplemented with 1% Insulin-Transferrin-Selenous acid (Collaborative biomedical
products, Bedford, MA), 10 ng.mL-1 TGF-β1 (R&D system, Minneapolis, MN), 5.33
μg.mL-1 linoleic acid, 1.25 μg.mL-1 bovine serum albumin, 1 mM sodium pyruvate, 100
U.mL-1 penicillin, 100 g.mL-1 streptomycin and 100 nM dexamethasone. A cell
suspension containing 2.0x106 cells in 100 μL of medium was dropped on the surface
of each scaffold (30 CF and 30 CS scaffolds) placed in untreated six-well non-tissue
culture plates. Each construct was allowed to incubate at 37˚C for one hour. After one
hour, 4.5 ml of chondrogenic medium was added to each well and the plates were
placed on a platform shaker oscillating at 60 rpm. The constructs were maintained at
37C and 5% CO2 in chondrogenic medium for 72 hours, 10 days, or 21 days. The
medium was changed three times a week.
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3.2.1.3. Evaluation of the Scaffolds:
The microstructure of the scaffolds (n = 3 per group) was evaluated by SEM.
Each scaffold was bisected in order to evaluate the surface as well as the central section
of the scaffold. Two sections per scaffold (superficial and centre) were mounted and
sputter coated with gold-palladium prior to examination with SEM (Hitachi S4700) at
1.0 kV.
Scaffolds (n = 5 per group) were weighed before and after dehydration to
determine water content.
Total surface area was determined with Brunauer, Emmett, and Teller
calculations in a surface area analyzer (ASAP2010 Gemini 2360, Micromeritics,
Norcross, GA) (Park et al, 2005). Briefly, a glass cell containing the scaffold was
placed into liquid nitrogen for gas adsorption onto each scaffold. Once the adsorption
of nitrogen gas was completed, the glass cell containing the scaffold was placed in a
water bath at ambient temperature and desorption of gas was calculated. Surface area
was measured on at least three samples for each type of scaffold.
3.2.1.4. Evaluation of Constructs:
Seeding was evaluated at 72 hours via SEM (n = 3 per group), dry (n = 5) and
wet (n = 8) weight measurements, and DNA quantification (n = 5). Chondrogenesis
was evaluated after 10 days of culture via SEM (n = 2 per group), dry (n = 5) and wet
(n = 9) weight measurements, and DNA and GAG quantifications (n = 5).
Chondrogenesis was evaluated after 21 days of culture via SEM (n = 2 per group),
live/dead assay (n = 2), histology (n = 2), dry (n = 6) and wet (n = 10) weights
measurements, DNA and GAG quantifications (n = 3), and quantitative real time
polymerase chain reaction (qRT-PCR) (n = 4).
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Scanning electron microscopy
The same construct fixation protocol as described above was used. Following
fixation, each construct was bisected in order to evaluate the surface as well as the
central section of the construct. A total of two sections per construct (superficial and
centre) were mounted for each construct and sputter coated with gold-palladium prior
to examination with SEM (Hitachi S4700) at 1.0 kV. Criteria evaluated included cell
morphology, cell attachment to the support, cell density, matrix production, and
chitosan integrity.
Histopathology
The constructs were fixed in 10% neutral buffered formalin, embedded in
plastic and cut via microtome to produce 1 µm-thick sections (Seddighi et al, 2008).
Sections were stained with Safranin-O Green. Slides were examined to evaluate cell
morphology, presence of ECM and integrity of the chitosan. The area containing
extracellular matrix was measured using the ImageJ program (National Institutes of
Health, Bethesda, MD) and expressed as a percent of the total area covered by the
construct in each image. Two images from each of the two samples per group were
included in the analysis.
Live/dead assay
The viability of cells in the constructs was determined using the live/dead
viability/cytotoxicity kit (Invitrogen) according to the manufacturer’s protocol.
Confocal microscopy (Olympus BX50 Confocal Microscope, Olympus) allowed the
visualization of calcein AM and ethidium homodimer-1. The intensities of viable and
dead cells were recorded on four slides per construct at a magnification of 40x and two
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slides at a magnification of 10x. The slides were analyzed using "Fluoview" software
(Olympus) to determine the percentage of viable cells.
Weights, water content, DNA and glycosaminoglycans
Specimens were weighed before and after dehydration to determine water
content.
The fluorometric assay described above was used to evaluate DNA content (Kim
et al, 1988). The cell seeding efficiency was calculated using the number of cells
contained in constructs after 72 hours of culture compared to the number of cells
initially seeded on each scaffold. The number of cells contained in the constructs was
calculated using the average DNA content per cell (11.4 pg per cell) evaluated by
fluorometric assay at the time of cell seeding on cell suspensions containing 106 and
5x106 cells.
The GAG content was evaluated via spectrophotometry as described above
(Farndale et al, 1986).
Quantitative real time PCR
Snap frozen constructs were pulverized in liquid nitrogen using a
dismembranator (Braun Biotech Int., Germany) (Reno et al, 1997). Total RNA was
isolated from the powdered tissue using the RNeasy mini kit (Qiagen, Valencia, CA)
according to the manufacturer’s instructions. The isolated RNA was treated on a
column with a DNase digestion kit (Qiagen) to eliminate genomic DNA contamination.
Subsequently, first-strand cDNA was synthesized using the High-Capacity cDNA
reverse Transcription Kits (Applied Byosystem, Foster City, CA). Quantitative real
time PCR (qRT-PCR) was performed using TaqMan® Universal PCR Master Mix
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(Applied Biosystems) with Mus musculus type I collagen (EMm00468761), type II
collagen (Mm00491889) and type X collagen (Mm00487041) Taqman® Gene
Expression Assays primer and probes (Applied Biosystems) and Eukaryotic 18s rRNA
Endogenous Control (Applied Biosystems). An ABI Prism 7000 Sequence Detection
System (Applied Biosystems) and its associated ABI 2.0 software were used to obtain
the data. The qRT-PCR reactions were carried out in 50 μL final volumes. Each sample
was run in triplicate. Thermal cycling was carried out for 40 cycles. The mRNA
expression levels of target genes were normalized by dividing their value by the value
of the 18s mRNA level. The gene expression levels in the chitosan fibrous scaffold
(CF) group relative to the chitosan sponge (CS) group were analyzed by the 2-∆∆CT
method using the CS group as the calibrator (Livak et al, 2001).
3.2.1.5. Statistical Analysis
Cell viability, dry and wet weights, DNA content, GAG content, GAG/DNA
ratio, and mRNA expression levels were compared between the sponge and fibrous
chitosan scaffolds with a risk factor of less than 0.05 considered statistically significant.
All data were expressed as mean ± standard deviation. Statistical differences were
evaluated between the CF and the CS constructs with a t-test using Systat 11.0
statistical software.
3.2.2. Results
3.2.2.1. Evaluation of the Scaffolds
The fiber diameter in the meshes and the pore size in the sponges were
homogeneous and respectively 13 µm in diameter and 120 µm in diameter (Figure 7).
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Figure 7: Scanning electron micrographs of the scaffolds. Left: Chitosan sponge
scaffold. Right: Chitosan fibrous scaffold. (100x)
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The water content of the CS scaffolds (97.7 ± 0.3%) was greater than that of the
CF scaffolds (95.4 ± 0.6%) (p = 0.042).
The total surface area of the CS scaffolds (9.2 m2.g-1) was greater than that of
the CF scaffolds (0.51 m2.g-1).
3.2.2.2. Seeding Phase:
Most MSCs exhibited a spindle-shape with prominent cytoplasmic extensions.
The cells tended to be grouped rather than uniformly distributed on the surface of both
types of scaffolds (Figure 8 A-B). Cell attachments in the center of the scaffolds did not
seem as abundant as at the periphery. No major difference in cell morphology, cell
attachment, and cell density between the different scaffold types was observed.
The wet weight of the CS constructs (143 ± 26 mg) was greater than that of the
CF constructs (78 ± 29 mg) 72 hours after seeding (p < 0.001). At 72 hours no
difference in dry weight was found between the two groups (6.0 ± 1.0 mg for CS and
4.5 ± 1.2 mg for CF, p = 0.112). The DNA content was also similar between CS
constructs (36.6 ± 6.3 μg.mg-1) and CF constructs (33.0 ± 8.8 μg.mg-1)(p = 0.475). The
cell seeding efficiency after 72 hours of culture averaged 85.04 ± 10.15% in all
scaffolds.
3.2.2.3. Evaluation of Chondrogenesis at ten and twenty-one Days:
Scanning electron microscopy
At 10 and 21 days, cells were embedded in ECM but did not appear to form
aggregates. All constructs appeared to contain more ECM after 21 days than after 10
days of culture. Fibrous scaffolds seemed to contain more ECM. The morphology of
cells changed from the spindle-shape after seeding to a rounder morphology at 21 days
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Figure 8: Scanning electron micrographs of constructs seeded with mesenchymal stem
cells. A: Chitosan fibrous scaffolds 72 hours after seeding. B: Chitosan sponges 72
hours after seeding. C: Chitosan fibrous scaffolds 21 days after seeding. D: Chitosan
sponges 21 days after seeding. (800x)
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(Figure 8). However, only cells not embedded in matrix could be observed. The
structural appearance of chitosan appeared intact after 21 days of culture in both groups
(Figure 8 CD).
Histopathology
Cell and ECM distribution were not homogeneous: more cells and ECM were
present in the periphery of the constructs. More ECM was subjectively observed in the
fibrous constructs (Figure 9). The chitosan structure appeared intact in all constructs.
The surface area covered by extracellular matrix on histology was 26.3 ± 19.2 % for the
CF constructs and 6.2 ± 2.5 % for the CS constructs. Despite the important variability,
a trend for increased extracellular matrix in the CF constructs was present (p = 0.083).
Weights, water content, live/dead assay, DNA and glycosaminoglycans
The dry weights did not differ between the two groups at all evaluation times
(6.5 ± 0.6 mg for CS and 6.0 ± 0.6 mg for CF at 10 days (p = 0.227) and 6.3 ± 0.9 mg
for CS and 5.8 ± 1.1 mg for CF at 21 days (p = 0.331)). The wet weight of the CS
constructs was greater than the CF constructs at 10 (131.3 ± 18.4 mg for CS and 93.5 ±
15.8 mg for CF, p < 0.001) and 21 days (135.6 ± 17.6 mg for CS and 95.7 ± 36.6 mg
for CF, p = 0.006). The water content of the CS constructs at 10 days (95.0 ± 0.7%)
was greater than that of the CF constructs (94.1 ± 0.3%)(p = 0.033). A similar trend
was present at 21 days, with a water content equal to 95.3 ± 0.6% for CS and 94.5 ±
0.77% for CF (p = 0.07).
The viability of the chondrocytes estimated by a live/dead fluorescent assay at
21 days did not differ between the two groups and was above 90% for all scaffolds
(96.2 ± 9% for CS and 95.6 ± 10% for CF, p = 0.538). The DNA content was not
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Figure 9: Histological Safranin-O Green stained sections. A: Chitosan fibrous scaffolds
21 days after seeding. B: Chitosan sponges 21 days after seeding. The scaffold is
stained in black.
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significantly different at 10 or 21 days after seeding between the two scaffold types
(35.8 ± 11.9 μg.mg-1 for CS and 44.7 ± 8.5 μg.mg-1 for CF at 10 days (p = 0.58) and
38.7 ± 8.8 μg.mg-1 for CS and 43.4 ± 3.9 μg.mg-1 for CF at 21 days (p = 0.15)).
The GAG content and the GAG/DNA ratios did not differ between the CF and
the CS groups at 10 days. At 21 days, CF constructs contained more GAG than CS
constructs (2.64 ± 0.32 μg.mg-1 dry weight and 0.93 ± 0.29 μg.mg-1 dry weight,
respectively; p < 0.01) (Figure 10). There was also a trend toward an increased
GAG/DNA ratio for the CF group (0.058 ± 0.004 for CF and 0.026 ± 0.015 for CS; p =
0.07).
Quantitative real time PCR
The level of mRNA expression for the type II collagen gene was three times
greater for the CF group compared to the CS group at 21 days (p = 0.04) (Figure 11).
No difference in type I collagen and type X collagen mRNA expression was found
between the two groups.
55
Figure 10: GAG content 21 days after seeding. A, B: groups with different letters differ
statistically (p < 0.05).
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Figure 11: mRNA expression level of type I collagen, type II collagen and type X
collagen, 21 days after seeding. A, B: groups with different letters differ statistically (p
< 0.05).
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3.3. Modification of the Chemical Composition of Chitosan Scaffolds to Improve
Mesenchymal Stem Cells Adhesion
3.3.1. Preliminary Study on Hyaluronic acid Coating
A preliminary study was performed to test the effects of HA coating on cell
adhesion, cell proliferation and extracellular matrix production of MSCs seeded on
fibrous scaffolds obtained with the wet spinning technique with (n = 22) or without HA
coating (n = 22). The scaffolds were prepared following the same protocol as described
in paragraph 3.2.1.1. The hyaluronic acid coating was obtained by placing the chitosan
scaffolds in a 0.5% sodium hyaluronate solution (Hylartin® V, Pfizer Animal Health
products, NY) for 12 hours prior to drying. MSCs were harvested at their fourth
passage and resuspended in chondrogenic medium as described in paragraph 3.2.1.2. A
cell suspension containing 2.0x106 cells in 100 μL of medium was dropped on the
surface of each scaffold. Each construct was allowed to incubate at 37˚C for one hour.
After one hour, 4.5 ml of chondrogenic medium was added to each well and the plates
were placed on a platform shaker oscillating at 60 rpm. The constructs were maintained
at 37C and 5% CO2 in chondrogenic medium for 72 hours, 10 days, or 21 days. The
medium was changed three times a week.
Following the same protocols as described in paragraph 3.2.1.4., seeding was
evaluated at 72 hours via SEM (n = 3 per group), dry (n = 5) and wet (n = 8) weight
measurements, and DNA quantification (n = 5). Chondrogenesis was evaluated after 10
days of culture via SEM (n = 2 per group), DNA and GAG quantifications (n = 5).
Chondrogenesis was evaluated after 21 days of culture via SEM (n = 2 per group),
live/dead assay (n = 2), DNA and GAG quantifications (n = 3). All data were expressed
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as mean ± standard deviation. Statistical differences were evaluated between the two
groups of constructs with a t-test using Systat 11.0 statistical software.
After seeding, most MSCs exhibited a spindle shape with prominent
cytoplasmic extensions. No major difference in cell focal adhesions and cell density
was observed between the different types of scaffolds. Cell attachment did not seem as
abundant in the center of the scaffolds as in the periphery. No difference in wet weight
(79.4 ± 16.0 mg), dry weight (4.7 ± 1.0 mg), and water content (93.67 ± 1.55%) was
found between groups after seeding. Uncoated chitosan fibrous constructs contained the
same amount of DNA (32.8 ± 9.7 μg.mg-1) compared to the HA-coated fibrous
constructs (31.7 ± 12.1 μg.mg-1).
All constructs appeared to contain more ECM after 21 days than after 10 days of
culture based on SEM evaluation. The morphology of cells changed from the spindle-
shape after seeding to a rounder morphology at 21 days. No difference was observed
between the two groups. The viability of cells at 21 days did not differ between the two
groups and was above 85% for all scaffolds. The DNA content was not significantly
different at 10 or 21 days after seeding between the two scaffold types (43.5 ± 7.38
μg.mg-1 for the non-coated and 37.4 ± 6.9 μg.mg-1 for the coated at 10 days and 41.4 ±
3.9 μg.mg-1 for the non-coated and 42.8 ± 6.9 μg.mg-1 for the coated at 21 days).
The GAG content ratios did not differ between the two groups at 10 and 21
days (2.11 ± 1.50 μg.mg-1 for the non-coated and 1.30 ± 0.41 μg.mg-1 for the coated at
10 days and 2.34 ± 0.20 μg.mg-1 for the non-coated and 2.01 ± 0.43 μg.mg-1 for the
coated at 21 days).
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3.3.2. Evaluation of the Degree of Deacetylation and type II Collagen Coating:
Materials and Methods
3.3.2.1. Scaffolds:
The chitosan (Texanmedtecho, Korea) used in this study has a molecular
weight of 400 kDA and a degree of deacetylation of 92%. Chitosan powder was
dissolved and stirred at room temperature for 48 hours in 2 wt. % aqueous acetic acid
solution to obtain a 4 wt. % chitosan solution.
Chitosan fibrous scaffolds were prepared using the wet spinning method
described above. Chitosan fibrous scaffolds were cut to measure 4 mm in diameter and
1.5 mm in height (group 1).
A portion of the chitosan fibers was reacetylated by suspension in 150 ml of
methanol and acetic anhydride (1 mol per glucosamine unit). The mixture was stirred at
40ºC for 24 hours. The treated fibers were washed several times with 100% ethanol,
and air-dried. Fibers were cut to 51 mm and carded to obtain the reacetylated chitosan
fibers web. The web was bonded by passing through the water-jet chamber and dried.
Reacetylated chitosan fibrous scaffolds were cut to measure 4 mm in diameter and 1.5
mm in height (group 3).
Two types of type II collagen solutions were used to coat the scaffolds.
Solution 1 was obtained by dissolving 10 mg of type II collagen (Calf type II collagen,
Elastin Products Company) in 10 ml of 0.4 mg.mL-1 of acetic acid. The two types of
scaffolds (chitosan and reacetylated chitosan) were placed in solution 1 for one hour.
The chitosan scaffolds dissolved in the collagen solution. The reacetylated chitosan
scaffolds were freeze-dried (group 4). Solution 2 was obtained by adding ethanol to
solution 1 at a concentration of 3 mg.mL-1 to prevent dissolution of chitosan scaffolds.
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The two types of scaffolds (chitosan (group 2) and reacetylated chitosan (group 5))
were kept in solution 2 for one hour and dried at room temperature.
A total of 30 scaffolds were prepared for each of the following groups:
1- Chitosan scaffolds
2- Collagen-coated chitosan scaffolds
3- Reacetylated chitosan scaffolds
4- Collagen-coated reacetylated chitosan scaffolds (without ethanol)
5- Collagen-coated reacetylated chitosan scaffolds (with ethanol).
All scaffolds had a dry weight of 1.98 ± 0.18 mg. They were sterilized with
ethylene oxide gas and rehydrated through a series of ethanol/PBS solutions (100, 95,
75, 50, 0% ethanol) (Marreco et al, 2004). The scaffolds were subsequently incubated
at 37°C on a shaker incubator in DMEM (ATCC) for 2 hours prior to cell seeding
(Griffon et al, 2006).
3.3.2.2. Mesenchymal Stem Cells:
The same mesenchymal cell line (D1 ORL UVA, ATCC) and same culture
medium as above were used for this study. Cells were harvested at their fourth passage
and suspended in medium prior to seeding. A cell suspension containing 1.0x106 cells
in 20 μL of medium was dropped on the surface of each scaffold (15 scaffolds per
group, 5 groups) and placed in untreated six-well non-tissue culture plates. Each
construct was allowed to incubate at 37˚C for one hour. After one hour, 4 ml of culture
medium was added to each well and the plates were placed on a platform shaker
oscillating starting at 30 rpm and increased to 60 rpm after 3 hours. The constructs
were maintained at 37C and 5% CO2 in culture medium for 24 hours, 48 hours, or 72
hours.
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3.3.2.3. Evaluation of the Scaffolds:
Fourier-transform infrared spectroscopy
Fourier-transform infrared (FTIR) spectra of each scaffold type (n = 3) were
analyzed by spectrophotometry (Nicolet Nexus FTIR 670, Thermo Electron, Waltham,
MA) of dehydrated specimens ground with potassium bromide powder and compressed
into pellets. Element analysis was used to determine the degree of substitution of the N-
acyl groups and the presence of collagen.
Scanning electron microscopy
Each scaffold (n = 2 per group) was mounted and sputter coated with gold-
palladium prior to examination with SEM at 1.0 kV. Criteria evaluated included fiber
size, surface characteristics, and the presence of type II collagen.
Transmission electron microscopy
The scaffolds (n = 2 per group) were fixed in a Karnovsky's fixative in
phosphate buffered 2% glutaraldehyde and 2.5 % paraformaldehyde. The scaffolds
were then washed in Sorenson's phosphate buffer. Microwave fixation was achieved
with 2% osmium tetroxide, followed by the addition of 3% potassium ferricyanide for
five minutes. After washing the samples, saturated uranyl acetate was added for one
hour. The specimens were dehydrated in a series of increasing concentrations of
ethanol. Acetonitrile was used as the transition fluid between ethanol and the epoxy. An
infiltration series was done with an epoxy mixture using the epon substitute Lx112. The
resulting blocks were polymerized at 90ºC overnight, trimmed and ultra-thin sectioned
with diamond knives. Transverse (n = 3) and longitudinal (n = 3) sections of 0.35 µm
were cut with diamond knives in each specimen. Light microscopy slides were made
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with one transverse and one longitudinal section and stained with Toluidine Blue O and
Basic Fucshine. Transmission electron microscopy (TEM) sections (two transverse and
two longitudinal sections) were stained with uranyl acetate and lead citrate, and
examined with a transmission electron microscope (Hitachi H600, Schaumburg, IL,
USA). Criteria evaluated included homogeneity of the fiber size, presence of a coating
at their surface and homogeneity of the coating.
Type II collagen content
Type II collagen content per scaffold (n = 3 per group) was determined by the
same enzyme linked immunosorbent assay (Arthrogen-CIA® Native Type II Collagen
Detection Kit, Chondrex) described above (Griffon et al, 2006).
Water content and porosity
Scaffolds (n = 5 per group) were weighed before and after dehydration to
determine their wet and dry weights, and water content.
The porosity was calculated using the equation (Chang et al, 2010):
Porosity (%) = [(Weight wet – Weight dry)/Water density] / Sample volume
The sample volume was 0.03 cm3 for all scaffolds. The water density was considered 1
g.cm-3.
Mechanical property of the chitosan and reacetylated chitosan scaffolds
The tensile properties of the scaffolds were evaluated according to ASTM D-
5035 using universal instron tester (Model LR5kPlus, Lloyd instrument Co). The
chitosan and reacetylated chitosan scaffolds were cut to 100 × 25 mm. Five specimens
were tested for each groups. A 5 Newton load cell was used at a constant rate of 100
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mm.min-1. The same tests were repeated after the scaffolds were placed in PBS buffer
solution at 37ºC for 1, 2, and 3 weeks. The breaking strength was measured to evaluate
the change of bulk properties and mechanical stability.
3.3.2.4. Evaluation of Constructs:
Evaluation of cell binding kinetics and cell viability
Cell binding kinetics and viability were evaluated after the initial incubation
phase, once fresh media was added to each well. The number of cells suspended in
medium and their viability were evaluated at one, two, four, six, 18 and 22 hours after
the initial seeding via trypan blue exclusion. Measurements were taken separately for
each scaffold type among two wells. The cell concentration in the medium was
compared for each time point (Vunjak-Novakovic et al, 1998).
Live/dead assay
The viability of cells in the constructs 48 hours after seeding was determined
using the live/dead viability/cytotoxicity kit (Molecular Probes) as described above.
Constructs (n = 2 per group) were washed three times in sterile PBS for two minutes,
placed on a glass slide, and immersed in 200 μL of PBS solution containing 2 mM
calcein AM and 4 mM ethidium homodimer 1 prior to incubation for 40 min at room
temperature. The intensities of viable and dead cells were recorded on four field of
view at a magnification of 40x.
Weights, water, and DNA content
Constructs were weighed 24 (n = 5 per group) and 72 (n = 5 per group) hours
after seeding before and after dehydration to determine their wet and dry weights,
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respectively. The water content was subsequently calculated. After dehydration, the
constructs were assayed for their DNA contents using the same fluorometric assay as
described above (Kim et al, 1988). The number of cells contained in the constructs was
calculated using the average DNA content per cell (5.34 pg per cell) as evaluated by
fluorometric assay at the time of cell seeding on cell suspensions containing 1x106 and
2x106 cells (Griffon et al, 2006).
The number of cells present in the well unattached to a scaffold was evaluated
by DNA quantification 24 (n=2 per group) and 72 (n=2 per group) hours after seeding.
The cell-media solutions were collected and centrifuged at 250 rpm.rcf-1 for ten
minutes and the pellet was assayed for DNA content using the above protocol.
Transmission electron microscopy
The evaluation protocol used for the constructs was similar to that described
above for the scaffolds. One construct per group was evaluated at 24, 48, and 72 hours
after seeding. The light microscopy slides were evaluated to assess the cell distribution.
Criteria evaluated via TEM included cell morphology, cell size, cell attachment to the
support, and presence of cytoplasmic extensions.
Histology
Light microscopy slides were made following the same protocol as described
above for TEM evaluation of the scaffolds. Histological sections were stained with
Toluidine Blue O and Basic Fucshine and evaluated to assess the cell distribution.
The constructs (n = 2 per group at 72 hours) were fixed in 10% neutral buffered
formalin, embedded in plastic and cut via microtome to produce three 8 µm-thick
sections (one superficial, one in the middle, and one at the bottom) (Seddighi et al,
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2008). Sections were stained with a trichrome stain. Slides were examined for cell
morphology, cell distribution within slides and between slides of the same construct,
and integrity of the scaffold.
Scanning electron microscopy
The same construct fixation protocol as above was used. A total of two sections
per construct (surface and bottom, n = 2 per group at 72 hours) were mounted for each
construct and sputter coated with gold-palladium prior to examination with SEM at 1.0
kV. Criteria evaluated included cell attachment to the support, presence of cytoplasmic
extensions, cell density, and integrity of the scaffold.
3.3.2.5. Statistical Analysis
Dry and wet weights, increase in dry weight, water contents, cell counts in
medium, cell viability, DNA content, and increase in DNA content between 24 and 72
hours were compared between the five groups with a risk factor of less than 0.05
considered statistically significant. All data were expressed as mean ± standard
deviation. Statistical differences were evaluated between the groups with an ANOVA
using Systat 11.0 statistical software. Post-hoc analyses were performed with the LSD
test.
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Figure 12: FTIR spectroscopy results. The Element analysis was used to determine the
degree of substitution of the N-acyl groups. The presence of collagen was confirmed in
the coated scaffolds by the presence of bands typical of amide I, II, and III (brace).
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3.3.3. Evaluation of the Degree of Deacetylation and type II Collagen Coating: Results
3.3.3.1. Evaluation of the Scaffolds:
Fourier transform infrared spectroscopy
The degree of deacetylation was 92% for the chitosan scaffolds and 4% for the
reacetylated chitosan scaffolds (Figure 12). The presence of collagen was confirmed by
the presence of bands typical of amide I (1658 cm-1), amide II (1552 cm-1), and amide
III (1240 cm-1) (Figure 12) (Cao et al, 2008).
Scanning electron microscopy
All fibers had a diameter of 13 to 15 µm. They appeared homogeneous within
scaffolds and among the different groups. The difference between chitosan and
collagen was difficult to distinguish because of similar contrast with SEM evaluation.
Transmission electron microscopy
All fibers appeared of similar size among all TEM samples. A layer of collagen
was observed at the surface of the fibers in all collagen-coated scaffolds (Figure 13).
No difference in coating was observed between the center and the periphery or between
scaffolds. Aggregation of collagen molecules was observed occasionally in the center
as well as in the periphery and in all types of collagen-coated scaffolds (Figure 13).
Type II collagen content
Type II collagen was not detected in the non-coated scaffolds. The type II
collagen content was 4.11 ± 1.39 μg.mg-1 for the collagen-coated chitosan scaffolds,
4.98 ± 0.15 μg.mg-1 for the collagen-coated reacetylated chitosan scaffolds (without
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Figure 13: Transmission electron micrographs of the edge of a fiber from a chitosan
scaffold (A) and a collagen-coated chitosan scaffold (B). The black arrow indicates the
collagen layer seen at the surface of the collagen-coated chitosan fiber; the arrowhead
indicates an aggregation of collagen molecules (50,000x).
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ethanol), and 8.04 ± 2.00 μg.mg-1 for the collagen-coated reacetylated chitosan
scaffolds (with ethanol). The collagen-coated reacetylated chitosan scaffolds contained
more type II collagen than the collagen-coated chitosan and the collagen-coated
reacetylated chitosan (without ethanol) scaffolds (p = 0.032 and p = 0.044,
respectively).
Water content and porosity
No difference was found in water content nor porosity among groups (mean
values among the different groups of 92.5 ± 1.8%, p = 0.653 and 86.4 ± 20.7%, p =
0.524, respectively) (Table 2).
Mechanical property of the chitosan and reacetylated chitosan scaffolds
The stress, strain and maximum load to failure of the chitosan and reacetylated
chitosan scaffolds are reported in Table 3.
3.3.3.2. Evaluation of Constructs:
Evaluation of cell binding kinetics and cell viability
Cell death in the medium was negligible (less than 5%) throughout the
experiment for all seeding techniques as assessed by trypan blue exclusion. Less than
10% of the cells remained in suspension one hour after the seeding for all scaffold
types. No difference in cell concentration was found until six hours after seeding. More
cells remained in suspension in the wells of the chitosan scaffolds than in other groups
six hours after seeding (p = 0.014) but this difference was not found at any later time
points (p > 0.497).
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Table 2: Summary statistics of the scaffold water content and porosity, the construct
water content, and the cell seeding efficiency of the scaffolds or constructs. A, B, C:
groups with different letters differ statistically (p < 0.05).
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Table 3: Mechanical properties and stability of the chitosan and reacetylated scaffolds
(mean ± standard deviation, n=5 per group).
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Live/dead assay
The viability of the MSCs estimated by a live/dead fluorescent assay 48 hours after
seeding did not differ among the five groups and remained above 83.6% for all
constructs (93.9% ± 8.9, p = 0.447).
Weights, water, and DNA content
No difference was found between groups in wet weight, dry weight and water
content after seeding (p = 0.249, p = 0.403, and p = 0.432, respectively). The water
content was 90.8 ± 2.6% (Table 2).
The DNA remained stable within groups from 24 to 72 hours after seeding. (p >
0.172 for all scaffold types). The average DNA content was 2.51 ± 0.46 μg for the
chitosan constructs, 4.37 ± 1.73 μg for the collagen-coated chitosan constructs, 1.36 ±
0.57 μg for the reacetylated chitosan constructs, 1.32 ± 0.19 μg for the collagen-coated
reacetylated chitosan constructs (without ethanol), and 1.25 ± 0.34 μg for the collagen-
coated reacetylated chitosan constructs (with ethanol) (Figure 14). The collagen-coated
chitosan constructs contained more DNA than any other constructs at 24 and 72 hours
(p < 0.001 for all comparisons). Chitosan constructs contained more DNA than the
collagen coated reacetylated chitosan constructs at 24 hours (p = 0.030 and p = 0.045)
and than all reacetylated chitosan constructs at 72 hours (p = 0.002 - 0.004). No
difference was found between the reacetylated chitosan constructs at either 24 or 72
hours (p > 0.696 and p > 0.856, respectively). The cell seeding efficiency after 24 hours
of culture was 47.2 ± 8.6% for the chitosan constructs, 81.8 ± 32.5% for the collagen-
coated chitosan constructs, 25.5 ± 10.7% for the reacetylated chitosan constructs, 24.6
± 3.6% for the collagen-coated reacetylated chitosan constructs (without ethanol), and
23.5 ± 6.4% for the collagen-coated reacetylated chitosan constructs (with ethanol)
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Figure 14: Average DNA content after seeding. A, B, C: groups with different letters
differ statistically (p < 0.05).
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(Table 2). The efficiency of cell seeding was greater on collagen-coated chitosan
scaffolds than any other construct (p < 0.001 for all comparisons). Seeding was
improved on chitosan scaffolds compared to all reacetylated chitosan constructs (p =
0.016-0.034). No difference was detected among the different reacetylated chitosan
constructs (p > 0.9).
No difference in the DNA content of the well was found after 24 hours
(p=0.588). However, the DNA content of the wells of chitosan constructs was greater
than the one of the wells of all other constructs at 72 hours (p=0.014).
Transmission electron microscopy
Cells exhibited similar morphological features typical of mesenchymal stem
cells including a spindle-shape and elliptical nucleus with usually multiple nucleoli,
various mitochondrial profiles, and small vacuoles. No difference in cell morphology
was observed between the constructs at 24, 48, and 72 hours after seeding. No
difference in cell attachment could be observed between the different groups.
Histology
The cell density and distribution among each construct was assessed with the
histological sections stained with Toluidine Blue O and Basic Fucshine. Findings were
in agreement with those of DNA content. The cell distribution also appeared to differ
among groups (Figure 15). Cells in chitosan constructs tended to be grouped rather than
uniformly distributed, whereas cell distribution seemed more uniform in collagen-
coated chitosan constructs. Although less obvious, a similar trend was observed in
reacetylated chitosan constructs where cells appeared more uniformly distributed along
collagen-coated fibers. Examination of the samples stained with trichrome confirmed
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Figure 15: Light microscopy images of the samples prepared for transmission electron
microscopy allowing evaluation of cell distribution within each construct. A: Chitosan
constructs. B: Collagen-coated chitosan constructs. C: Reacetylated chitosan constructs.
D: Collagen-coated reacetylated chitosan constructs (without ethanol). E: Collagen-
coated reacetylated chitosan constructs (with ethanol) (10x).
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the findings obtained with the light microscopy slides of the TEM in terms of
subjective cell numbers and distribution among groups. Cells exhibited the appearance
of MSCs in all constructs. The chitosan structure appeared intact in all constructs.
Scanning electron microscopy
Most MSCs exhibited a spindle-shape with prominent cytoplasmic extensions.
No major differences in cell morphology were observed among groups. The cells
tended to be uniformly distributed within each evaluated surface (surface or bottom).
However, marked differences in cell density were observed (Figure 16). The
reacetylated chitosan constructs contained fewer cells at the surface and at the bottom
than the chitosan-based constructs. More cells were present at the surface and at the
bottom of collagen coated chitosan constructs had than in all the other groups. The
presence of collagen was associated with a more even distribution of cells, with more
cells attached at the bottom of the constructs and cells spreading along the fibers rather
than grouped in clumps. It was not possible to count the cells because they exhibited a
spindle-shape with prominent cytoplasmic extensions and tended to form sheets.
Finally, the structural integrity of fibers seemed intact in all groups.
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Figure 16: Scanning electron micrographs of the constructs 72 hours after seeding with
MSCs. A: Surface of a chitosan construct. B: Surface of a collagen-coated chitosan
construct. C: Bottom of a chitosan construct. D: Bottom of a collagen-coated chitosan
construct. E: Surface of a reacetylated chitosan construct. F: Surface of a collagen-
coated reacetylated chitosan construct (100x).
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3.4. Effect of Type II Collagen Coating of Chitosan Fibrous Scaffolds on Mesenchymal
Stem Cells Adhesion and Chondrogenesis
3.4.1. Materials and Methods
3.4.1.1. Scaffolds
The chitosan (Texanmedtecho, Korea) used in this study has a molecular
weight of 400 kDA and a degree of deacetylation of 92%. Chitosan powder was
dissolved and stirred at room temperature for 48 hours in 2 wt. % aqueous acetic acid
solution to obtain a 4 wt. % chitosan solution. Chitosan fibrous scaffolds were prepared
using a wet spinning method described above. Chitosan fibrous scaffolds were cut to
measure 4 mm in diameter and 1.5 mm in height (Chi, n = 30). Two solutions of type II
collagen were obtained by dissolving 10 mg and 20 mg of type II collagen (Calf type II
collagen, Elastin Products Company, Owensville, MI) in 5 ml of 0.4 mg.mL-1 of acetic
acid and 3 mg.mL-1 of ethanol. Chitosan fibrous scaffolds were dipped for one hour in
the 2 mg.mL-1 (Chi-Col 2, n = 30) or in the 4 mg.mL-1 (Chi-Col 4, n = 30) type II
collagen solution and dried at room temperature. The reference group consisted of a
polyglycolic acid mesh previously tested for in vitro chondrogenesis (PGA, n = 30,
Synthecon Inc.) (Griffon et al, 2005; Griffon et al, 2006; Seddighi et al, 2008). The
average dry weight of the final scaffolds was 2.92 ± 0.34 mg. All scaffolds were
sterilized with ethylene oxide gas and rehydrated through a series of ethanol/PBS
solutions (100, 95, 75, 50, 0% ethanol) (Marreco et al, 2004). Scaffolds were
subsequently incubated at 37°C on a shaker incubator in DMEM (ATCC) for two hours
before cell seeding.
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3.4.1.2. Mesenchymal Stem Cells:
The same mesenchymal cell line (D1 ORL UVA, ATCC) was used. Cells were
harvested at their fourth passage prior to seeding. A cell suspension containing 1.0x106
cells in 20 μL of medium was dropped on the surface of each scaffold placed in
untreated six-well non-tissue culture plates. Each construct was incubated at 37˚C for
one hour. After one hour, 4 ml of culture medium was added to each well and the plates
were placed on a platform shaker oscillating at 30 rpm and increased to 60 rpm after 3
hours. After 48 hours, the media was changed with chondrogenic medium. The
chondrogenic medium was the same as described above. The medium was changed
three times a week. The constructs were maintained at 37C and 5% CO2 under
dynamic condition for 48 hours or 21 days.
3.4.1.3. Evaluation of the Scaffolds:
Fourier-transform infrared spectroscopy
Fourier-transform infrared spectra of each scaffold type (n=3) were analyzed by
a spectrophotometer (Nicolet Nexus FTIR 670) using dehydrated specimens ground
with potassium bromide powder and compressed into pellets. Element analysis was
used to determine the presence of collagen.
Scanning electron microscopy
Each scaffold (n = 2 per group) was mounted and sputter coated with gold-
palladium prior to examination with SEM (Hitachi S4700) at 1.0 kV. Criteria evaluated
included fiber size (based on random measurements on ten fibers per scaffold) and
surface characteristics.
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Transmission electron microscopy
The scaffolds (n = 2 per group) were fixed using the same fixation protocol was
used as described above. For each scaffold, a transverse section and a longitudinal
section were evaluated. Light microscopy slides were made at 0.35 µm and stained with
toluidine blue O and basic fucshine. TEM sections were stained with uranyl acetate and
lead citrate, and examined with a transmission electron microscope (Hitachi H600).
Criteria evaluated included presence and homogeneity of the coating at the surface of
the fibers.
Type II collagen content
Type II collagen content per scaffold (n = 3 per group) was determined by the
same enzyme linked immunosorbent assay (Arthrogen-CIA® Native Type II Collagen
Detection Kit, Chondrex) as described above (Griffon et al, 2006).
3.4.1.4. Evaluation of the Constructs:
Seeding was evaluated at 48 hours via live/dead assay (n = 1 per group), dry
and wet weight measurements (n = 5), DNA quantification in the constructs (n = 5) and
in the medium of the well (n = 3), SEM (n = 2), TEM (n = 1). Chondrogenesis was
evaluated after 21 days of culture via dry and wet weight measurements (n = 5), DNA
and glycosaminoglycan (GAG) quantification (n = 5), SEM (n = 2), TEM (n = 2),
histology (n = 2), and quantitative real time polymerase chain reaction (qRT-PCR) (n =
4).
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Live/dead assay
The viability of cells in the constructs 48 hours after seeding was determined
using the same method as described above. The intensities of viable and dead cells
were recorded on two field views at a magnification of 10x and four field views at a
magnification of 40x. The slides were analyzed using a specific software (Fluoview,
Olympus) to determine the percentage of viable cells.
Weight, DNA and glycosaminoglycans content
Constructs were weighed after dehydration and digested in papain for 16 hours
at 60C. The same fluorometric and specrtophotometric assays as described above were
used to evaluate the DNA and GAG contents, respectively (Kim et al, 1988). The
number of cells contained in the constructs was calculated using the average DNA
content per cell (6.49 pg per cell) evaluated on cell suspensions containing 1x106 and
2x106 cells at the time of cell seeding (Griffon et al, 2006). The GAG/DNA ratio was
obtained by dividing the GAG content (μg) by the DNA content (μg).
After 48 hours, the media and cells left in the wells after the harvest of the
constructs were collected and centrifuged (n = 3 per group). Each pellet was assayed
for their DNA content.
Scanning electron microscopy
Constructs were fixed using the method described above. A total of two
sections per construct (surface and bottom) were mounted and sputter coated with gold-
palladium prior to examination with SEM at 1.0 kV. Criteria evaluated included cell
morphology, cell attachment to the support, cell density, matrix production, and
chitosan integrity. It was not possible to count the cells because they exhibited a
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spindle-shape with prominent cytoplasmic extensions and tended to form sheets or
were embedded in ECM (Griffon et al, 2005; Griffon et al, 2006).
Transmission electron microscopy
The constructs were fixed following the same protocol as described above. The
light microscopy slides were evaluated to assess the cell density and distribution.
Criteria evaluated with TEM after seeding included cell morphology and presence of
cytoplasmic extensions. Criteria evaluated with TEM after 21 days of culture included
cell morphology and the production of ECM.
Histopathology and immunohistochemistry
The constructs were fixed in 10% neutral buffered formalin, embedded in
plastic and cut via microtome to produce 6 µm-thick sections (Seddighi et al, 2008).
One section from the surface, the middle, and the bottom of each construct were stained
with safranin-O fast Green and examined to evaluate cell morphology, presence of
ECM, and integrity of the biomaterial. A picture of each section was taken at a
magnification of 10x. For each picture, the area containing ECM was measured using
the ImageJ program (National Institutes of Health) and expressed as a percent of the
total area.
Immunostaining was performed using rabbit polyclonal antibody against
aggrecan (Millipore, Billerica, MA, USA) using a 1:100 dilution factor after treatment
with chondroitinase (Associates of Cap Code, East Falmouth, MA, USA) in 0.1%
bovine serum albumin. One section from the surface, the middle, and the bottom of
each construct were stained and evaluated for the density and intensity of the
immunostaining.
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Quantitative real time PCR
Snap frozen constructs were pulverized in liquid nitrogen using a
dismembranator (Braun Biotech Int.) (Reno et al, 1997). Total RNA was isolated from
the powdered tissue using the RNeasy mini kit (Qiagen) according to the
manufacturer’s instructions. The isolated RNA was treated on a column with a DNase
digestion kit (Qiagen) to eliminate genomic DNA contamination. The quality of the
RNA was evaluated using the ribosomal ratio and the RNA integrity number obtained
with a bioanalyzer (Agilent 2100 bioanalyzer, Foster city, CA, USA). Subsequently,
first-strand cDNA was synthesized using the high-capacity cDNA reverse transcription
kit (Applied Biosystem). qRT-PCR was performed using TaqMan® universal PCR
master mix (Applied Biosystems) with Mus musculus type I collagen (Mm468761),
type II collagen (Mm491889), type X collagen (Mm487041), and aggrecan
(Mm545794) Taqman® primer and probes and eukaryotic 18s rRNA and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) endogenous controls. An ABI
Prism 7000 Sequence Detection System (Applied Biosystems) and the ABI 2.0
software were used to obtain the data. The qRT-PCR reactions were carried out in 25
μL final volumes for 45 cycles. Each sample was run in triplicate. The mRNA
expression levels of target genes were normalized to the GAPDH mRNA level. The
gene expression levels were compared using the 2-∆∆CT method (Chen et al, 2008;
Livak et al, 2001).
3.4.1.5. Statistical Analysis
Cell viability, water content, dry weights, percent increase in dry weight, DNA
content, GAG content, GAG/DNA ratio, and mRNA expression levels were compared
between the groups with a risk factor of less than 0.05 considered statistically
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significant. All data were expressed as mean ± standard deviation. Statistical
differences were evaluated between the groups with an ANOVA using Systat 11.0
statistical software. Post-hoc analyses were performed with the least significant
difference test. Correlations between collagen content and DNA content after seeding
were estimated and tested for significance using the nonparametric Spearman rank
correlation coefficient.
3.4.2. Results
3.4.2.1. Evaluation of the Scaffolds:
The presence of collagen was confirmed with the FTIR spectra by the presence
of bands typical of amide I (1658 cm-1), amide II (1552 cm-1), and amide III
(1240 cm-1) (Cao et al, 2008).
The diameter of the fibers evaluated by SEM was 15.47±2.18 µm and no
difference was found between groups (Table 4). The difference between chitosan and
collagen within coated scaffolds was difficult to distinguish due to their similar
contrasts in SEM.
A layer of collagen was observed by TEM at the surface of the fibers in all
collagen-coated scaffolds (Figure 17). No difference in coating was observed between
the center and the periphery within each scaffold. The coating appeared thicker for the
Chi-Col 4 scaffolds.
Type II collagen was not detected in the non-coated scaffolds. The type II
collagen content was 13.10 ± 3.25 μg.mg-1 for the Chi-Col 2 scaffolds and 22.29 ± 1.53
μg.mg-1 for the Chi-Col 4 scaffolds (Table 4). The collagen coated scaffolds contained
more collagen than the non-coated scaffolds (p < 0.001) and the Chi-Col 4 scaffolds
contained more type II collagen than the Chi-Col 2 scaffolds (p = 0.002).
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Table 4: Summary statistics of the characteristics of the scaffolds and constructs after
seeding and culture. A, B, C: Groups with different letters differ statistically. *:
Denotes a trend with 0.05 < p < 0.1. §: Denotes a difference with the PGA group and a
trend with the Chi group.
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Figure 17: Transmission electron microscopy of the edge of a fiber from a chitosan
scaffold (A), a Chi-Col 2 scaffold (B), and a Chi-Col 4 scaffold (C) (50,000x). Black
arrow indicates the collagen layer at the surface of the chitosan fiber.
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3.4.2.2. Evaluation of Constructs after Seeding
Live/dead assay
The viability of the MSCs estimated with the live/dead assay 48 hours after
seeding did not differ between the four groups (82.7% ± 5.9, p = 0.464) (Figure 18).
Weight and DNA content
No difference in dry weight was found between groups of constructs (p=0.731).
The water content of the PGA constructs was greater at 48 hours than the water content
of the Chi-Col 2 and Chi-Col 4 constructs (Table 4). The water content of the Chi
constructs was greater than the water content of the Chi-Col 2 constructs.
Collagen coated constructs contained more DNA than PGA constructs (p<0.1,
Table 4). The Chi-Col 4 constructs contained more DNA than the Chi constructs
(p=0.035). No difference was found between the PGA and Chi constructs (p=0.103).
The cell seeding efficiency after 48 hours of culture was 57.5±15.4% for the Chi
constructs, 68.5±14.7% for the Chi-Col 2 constructs, 81.0±21.7% for the Chi-Col 4
constructs, and 39.9±10.7% for the PGA constructs (Table 4). A correlation was found
between the collagen concentration of the chitosan scaffolds and the DNA content after
seeding (Spearman-rho = 0.529, p=0.04). The coefficient of the linear regression
corresponded to 20,000 more cells attaching on the scaffold for an increase in type II
collagen content of one microgram per milligram. No difference in the DNA content of
the media was found after 48 hours (p=0.680).
Scanning electron microscopy
Most MSCs exhibited a spindle-shape with prominent cytoplasmic extensions.
No major difference in cell morphology was observed between the different groups.
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Figure 18: Confocal microscopy view of a Chi-Col 4 construct 48 hours after seeding
(40x). The cells are spreading along the fibers and display the green intensity of live
cells.
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The cells tended to be uniformly distributed within each evaluated surface but more
cells were observed at the surface. Marked differences in cell density were observed
between constructs (Figure 19). The PGA and Chi constructs had fewer cells than the
collagen-coated constructs. This difference was more important for the bottom section.
The Chi-Col 4 constructs contained more cells than all the other groups.
Transmission electron microscopy
The cell density and distribution among each construct was assessed with light
microscopy. The collagen-coated chitosan constructs contained more cells than the
other constructs. The cells in the chitosan constructs tended to be grouped rather than
uniformly distributed. This finding differed from the collagen-coated chitosan
constructs and the PGA constructs in which cells tended to be more uniformly
distributed along the fibers. With TEM, cells exhibited similar morphological features
typical of mesenchymal stem cells including a spindle-shape and elliptical nucleus with
usually multiple nucleoli, various mitochondrial profiles, and small vacuoles (Figure
20).
3.4.2.3. Evaluation of Constructs after twenty-one Days of Culture:
Weight, DNA and glycosaminoglycans content
The percent increase in dry weight and the final dry weight were greater for all
chitosan constructs compared to PGA (p < 0.001) and for the Chi-Col 2 and Chi-Col 4
constructs compared to the Chi constructs (p = 0.033 and p = 0.015, respectively; Table
4). The collagen-coated chitosan constructs contained more DNA and had improved
cell proliferation compared to the Chi and PGA constructs (p < 0.001 and p < 0.04,
respectively; Table 4). The collagen-coated chitosan constructs contained more GAG
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Figure 19: Scanning electron microscopy of the bottom of the constructs 48 hours after
seeding with MSCs (100x). A: Chi construct. B: Chi-Col 2 construct. C: Chi-Col 4
construct. D: PGA construct.
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Figure 20: Transmission electron microscopy illustrating the typical appearance of the
cells 48 hours after seeding on a Chi-Col 4 scaffold (2,500x). Cells exhibited similar
morphological features typical of mesenchymal stem cells including a spindle-shape
and elliptical nucleus with usually multiple nucleoli, various mitochondrial profiles,
and small vacuoles.
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than the Chi and PGA constructs (p < 0.03 for all comparison, Table 4). The
GAG/DNA ratio was greater for the chitosan constructs (1.38 ± 0.20) compared to the
Chi-Col 2 and Chi-Col 4 constructs (0.96 ± 0.33 and 0.99 ± 0.34, p<0.04).
Scanning electron microscopy
For all groups, more cells were present at the surface of the constructs. Marked
differences in cell density and morphology were observed between the different groups.
The collagen coated chitosan constructs contained more cells than the PGA and Chi
constructs. Most cells seeded on the Chi-Col 2 and Chi-Col 4 scaffolds had the
phenotypic appearance of normal chondrocytes. However, isolated cells tended to be
stellate in shape, with prominent cytoplasmic extensions. Conversely, a greater
proportion of cells in the Chi constructs and most cells in the PGA constructs had the
phenotypic appearance of MSCs (Figure 21 A-D). The cells were embedded in ECM
(Figure 21 A-D). More matrix was seen in the collagen coated constructs. The amount
of ECM observed within the constructs appeared to correlate with the phenotypic
appearance of the cells, more matrix being noted around cells that had the phenotypic
appearance of normal chondrocytes. Finally, the structural appearance of the scaffolds
appeared intact in all chitosan groups whereas the fibers of the PGA mesh seem to have
broken in shorter fragments.
Transmission electron microscopy
The cells were embedded within ECM throughout most evaluated constructs (Figure
22). In the collagen coated constructs, the majority of cells had the appearance of
chondrocytes with prominent nuclei and containing the different cytoplasmic organelles
such as endoplasmic reticulum, Golgi apparatus and vacuoles (Figure 22 C). An
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Figure 21: Scanning electron micrographs of the constructs 21 days after seeding with
MSCs. A: Surface of a Chi construct. The cells are spreading between the fibers and
most cells have the phenotypic appearance of MSCs (100x). B: Surface of a Chi-Col 4
construct. Most cells have the phenotypic appearance of normal chondrocytes (100x).
C: Cells having the phenotypic appearance of MSCs in a Chi construct (800x). D: Cells
having the phenotypic appearance of normal chondrocytes in a Chi-Col 4 construct
(800x).
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abundant ECM was observed in the pericellular, inter- and intra-territorial zones
containing fibrillar collagens which were faintly cross-banded and randomly oriented
(Figure 22 B). In the chitosan and PGA constructs, the ECM was less important in the
intra-territorial zone. In the PGA constructs, enlarged individual cisternae of rough
endoplasmic reticulum and cells colonizing cracks within broken fibers were observed
(Figure 22 A) (Leighton et al, 2007).
Histopathology and immunohistochemistry
For all constructs, more cells and ECM were observed in the periphery of the
constructs. The surface area covered by ECM was greater for the collagen coated
constructs compared to the Chi and PGA constructs (Table 4). The chitosan structure
appeared intact in all constructs whereas some PGA fibers were fragmented.
Aggrecan levels were increased in the collagen-coated chitosan constructs compared to
the PGA and Chi constructs as evaluated by immunohistochemistry (Figure 23). The
matrix of the Chi-Col 4 constructs had strong immunoreactivity for aggrecan,
predominantly within the pericellular matrix of the cells.
Quantitative real time PCR
At 21 days, more type II collagen mRNA was expressed in the collagen coated
chitosan constructs compared to the PGA constructs (383% increase, p = 0.016) and a
trend was present for a greater expression of aggrecan mRNA in the collagen coated
chitosan constructs compared to the PGA constructs (216% increase, p = 0.089). There
was a trend for a greater expression of type II collagen mRNA in the collagen coated
chitosan constructs compared to the chitosan constructs (231% increase, p = 0.057).
The level of mRNA expression for type X collagen was greater in all chitosan-based
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Figure 22: Transmission electron micrographs of the constructs 21 days after seeding
with MSCs. A: PGA construct (1,500x). B: Chi-Col 4 construct (1,500x). C: Chi-Col 4
construct (5,000x). An abundant ECM is observed in the pericellular and interterritorial
zones ( ). In the PGA constructs, enlarged individual cisternae of rough endoplasmic
reticulum were observed (arrow) and cells were colonizing the cracks of the broken
fibers (arrowhead).
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Figure 23: Aggrecan immunohistochemical staining of the constructs 21 days after
seeding with MSCs (100x). A: Chi construct, B: Chi-Col 2 construct, C: Chi-Col 4
construct, D: PGA construct. Aggrecan staining was increased with the collagen
coating (B,C). The Chi-Col 4 constructs resulted in the highest immunoreactivity for
aggrecan in the pericellular matrix.
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constructs compared to the PGA (288 to 308% increase, p < 0.002). The level of
mRNA expression for the type I collagen gene was not different between the chitosan,
collagen coated chitosan, and PGA constructs (p = 0.39).
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Figure 24: Relative matrix gene expression in the engineered constructs analyzed by
real-time quantitative RT-PCR after 21 days (relative to PGA).
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CHAPTER 4: DISCUSSION
Chitosan scaffolds previously tested for cartilage tissue engineering do not
fulfill all the criteria necessary for clinical application because of their decreased
properties for cell adhesion. The effects of their structural characteristics have not been
evaluated for cartilage engineering applications. Their chemical composition can be
modified to improve cell adhesion for tissue engineering. The main findings of this
project are the following:
(1) Fibrous chitosan scaffolds produced by the replica molding technique are effective
matrices for cartilage tissue engineering.
(2) Chitosan constructs contained less chondrocytes than the PGA constructs of similar
structure but the amount of matrix produced by individual chondrocytes was greater in
chitosan than in PGA constructs. The early breakdown of PGA fibers may limit their
use for cartilage tissue engineering.
(3) Chondrogenesis on chitosan was improved in fibrous scaffolds compared to
sponges.
(4) Decreasing the DD of chitosan scaffolds limits cell adhesion and cannot be
effectively overcome by type II collagen coating.
(5) Type II collagen coating improves cell adhesion, cell distribution, and
chondrogenesis on chitosan fibrous scaffolds.
4.1. Chitosan Scaffolds for Cartilage Tissue Engineering
Individual cells produced more ECM on chitosan compared to PGA. This
difference in matrix production per individual cells is more likely due to the chemical
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composition than the structural characteristics of the scaffolds, since one of our
chitosan groups was composed of fibers of similar width to those of the PGA mesh (13
µm). The chemical nature of chitosan initially prompted the interest for this biomaterial
as a candidate for cartilage engineering and was later offered as an explanation for the
chondrogenesis observed on chitosan sponges (Di Martino et al, 2005; Madihally et al,
1999; Mao et al, 2004; Nettles et al, 2002; Suh et al, 2000). This natural polysaccharide
degrades to GAGs such as chondroitin, chondroitin-sulfate, dermatane-sulfate, keratin-
sulfate and hyaluronic acid. These physiological components of the extracellular matrix
of native cartilage contribute to the synthesis of proteins by chondrocytes (Bostman et
al, 1990; Lu et al, 1999; VandeVord et al, 2002). Another mechanism that may have
contributed to our results relates to the type of adhesion formed between chondrocytes
and PGA fibers. Some chondrocytes were found to display a stellate appearance on
SEM examination of PGA constructs, a potential sign of dedifferentiation. Although we
did not investigate gene expression of these cells, dedifferentiated chondrocytes would
be expected to produce less GAG and type II collagen.
Chondrocytes also exhibited a different behavior in terms of attachment to PGA
versus chitosan scaffolds. The seeding yield was three times lower on chitosan
compared to PGA. The decreased yield on chitosan scaffolds accounts for their lower
cell content compared to PGA constructs after three weeks of culture. Cell attachment
to 3-D matrices depends on the initial number and viability of cells, the seeding
technique and the characteristics of the scaffold (Vunjak-Novakovic et al, 1998).
Chondrocytes were harvested from young, healthy animals. The use of healthy cells
allows us to eliminate poor viability as a potential cause for the lack of cell attachment
to the chitosan scaffolds, although our results may not be extrapolated to chondrocytes
collected on a patient requiring joint resurfacing. Similar differences in yield rate were
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previously reported when chondrocytes were seeded on chitosan sponges and the PGA
mesh included in our study (Griffon et al, 2005; Griffon et al, 2006). The difference in
DNA content and cell counts is more likely due to a difference in chemical composition
rather than structural properties of the scaffolds. The mechanisms proposed to explain
the influence of chemical composition of the biomaterial on direct cell adhesion relate
to the presence of adhesion peptides along the surface of the matrix and the surface
hydrophobicity (Evans et al, 1998; Jeschke et al, 2002). The PGA mesh used in our
study lacks functional groups for cell recognition but dissolved within 21 days of
incubation in acellular media (Cui et al, 2003; Tsai et al, 2006; Zhu et al, 2002). On the
other hand, cell attachment on chitosan should be enhanced by the surface energy of
this polysaccharide resulting from its hydrophilic nature (Moroni et al, 2006). The
chitosan used in our study was specifically selected for its high DD and low molecular
weight, two characteristics expected to encourage cell adhesion (Hamilton et al, 2006;
Mao et al, 2004). The discrepancy between our results and expected yield at 48 hours
may be explained by a two-step process recently proposed to contribute to cell
attachment, whereby proteins contained in the media are absorbed by the scaffold and
provide sites of attachment for cells (Mahmood et al, 2004). Under these premises, the
cell adhesion characteristics of a biomaterial may not be directly related to direct cell-
matrix interactions but to the differential adsorption of proteins present in the culture
medium to the biomaterial (Chastain et al, 2006).
4.2. Fibrous Scaffolds for Cartilage Tissue Engineering
Individual cells recognize structures with dimensions comparable to them (10-
100 µm) (Mooney et al, 2003). Therefore, micro-scale characteristics should be
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considered when designing scaffolds for tissue engineering. These microstructural
characteristics can selectively activate genes and modulate cellular behavior with
regards to proliferation and differentiation (Chen et al, 2007; Griffon et al, 2006; Li et
al, 2006; Moroni et al, 2006; Sasmazel et al, 2008; Yamane et al, 2006). However, the
influence of the microstructure of 3-D scaffolds on chondrocytes and on MSCs
chondrogenesis remains poorly understood (Lee et al, 2008).
Our findings using fibrous scaffolds obtained by the replica molding technique
confirm the chondrogenesis previously reported on fibrous scaffolds composed of
microfibers ranging from 13 to 30 µm in diameter (Freed et al, 1994; Seddighi et al,
2008). The lower DNA content and cell seeding efficiency of the 4 µm-width fibrous
chitosan constructs after 48 hours of culture in our study suggests that decreasing the
diameter of chitosan fibers may affect cell adhesion. Moroni et al. reported similar
results, with mesenchymal stem cells attaching preferentially to 10 µm-diameter fibers
compared to fibers of smaller diameter (Moroni et al, 2006). Larger fibers provide
spacious surface for the cells to attach, facilitating the formation of secure focal
adhesions and thereby improving yield rates. The dimensions of fibers affect other
microstructural characteristics such as porosity, permeability, pore size distribution,
and surface area, which may also influence cell behavior. For example, cell seeding
yield and cell proliferation are affected by the porosity and the pore characteristics of 3-
D matrices (Griffon et al, 2006; Lee et al, 2008; Mukherjee et al, 2009; Sasmazel et al,
2008; Yamane et al, 2006). Although all chitosan fibers had similar water content, we
cannot eliminate the potential influence of porosity, pore size, geometry and
interconnectivity on the characteristics of the final constructs. The results obtained with
fibrous scaffolds of different width suggest that the structural characteristics of a
scaffold may have more impact on cell proliferation and ECM production than initial
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cell adhesion and cell-cell interaction. Indeed, DNA, GAG and collagen contents did
not differ between the different chitosan constructs cultured for 21 days, in spite of a
decreased cell density on smaller fibers. Higher chondrocyte density was previously
correlated with increased amount of GAG and collagen and cartilaginous
histomorphologies, presumably due to enhanced cell-cell interactions (Vunjak-
Novakovic et al, 1998). Also, the number of cell attached to the scaffold was found to
exert a strong influence on the biochemical composition of the constructs and the
amount of ECM components accumulated in the tissues on a per-cell basis
(Mahmoudifar et al, 2006). Our findings would be consistent with enhanced
chondrocyte proliferation and matrix production on scaffolds composed of smaller
fibers. This concept is supported by Li et al., who previously described increased cell
proliferation and GAG content when chondrocytes were cultured on nanofibrous
synthetic scaffolds compared to microfibrous scaffolds (Li et al, 2006). These effects
may be mediated by changes in 3-D cytoskeleton occurring when a greater number of
secure adhesions form between cells and larger fibers. This cytoskeletal network is
composed of actin microfilaments, microtubules, and intermediate filaments known to
play key roles in cell signaling, intracellular transport, cell-matrix interactions and cell
differentiation (Mooney et al, 1995; Woods et al, 2007). Scaffolds composed of smaller
fibers may therefore prompt cells to express proper proteins and signals via cytoskeletal
networks (Moroni et al, 2006). In that respect, non-woven fibrous scaffolds approach
the random arrangement of fibers in native ECM more closely than a woven mesh of
perpendicular fibers stacked in multiple layers (Yamane et al, 2005).
We found that the GAG content and the type II collagen expression by MSCs
are enhanced at 21 days in fibrous chitosan constructs compared to sponges. These
findings support the concept that altering structural characteristics of a scaffold may be
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a viable strategy to promote chondrogenesis by MSCs. Indeed, all scaffolds in this
study were produced with the same batch of chitosan, thereby eliminating chemical
composition as a possible confounder for our results. We can also eliminate variation in
cell numbers as a potential explanation for the differences between our groups, since
the DNA content did not differ between constructs at any time during our study. The
increased expression of type II collagen mRNA with no difference in expression of
type X collagen mRNA in meshes is consistent with improved MSCs chondrogenesis
without hypertrophic changes (Pelttari et al, 2006). The absence of difference for type I
collagen and type X collagen could however be due to a type II error. Fibrous scaffolds
simulate more closely than sponges the structure of native cartilaginous ECM,
comprised of collagen fibrils (Moroni et al, 2006). Our results strengthen the argument
for developing biomimetic scaffolds to control cellular functions and direct cell-cell
interactions toward the formation of a specific tissue (Hubbell, 1995). The effect of
microstructure in cartilage tissue engineering has been previously evaluated with
chondrocytes on sponges of different pore sizes (Chen et al, 2007; Griffon et al, 2006;
Li et al, 2006; Moroni et al, 2006; Sasmazel et al, 2008; Yamane et al, 2006). However,
the difference in extracellular matrix production could have been related to difference
in cell numbers between the groups. Improved cartilage tissue formation on fibrous
scaffolds has been suggested when chondrocytes were cultured in vivo on poly(ethylene
glycol)-terephthalate/poly-butylene terephthalate (Malda et al, 2005). Although these
results were promising, we could not find any previous report of a similar influence of
the environmental microstructure on MSCs chondrogenesis. Instead, the development
of biomimetic scaffolds to enhance chondrogenic differentiation of MSCs has largely
focused on altering the chemical composition rather than the structural characteristics
of scaffolds. For example, glucosamine, a precursor of cartilage components, was
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shown to direct cell differentiation and cartilage tissue formation when incorporated in
hydrogels (Hwang et al, 2006). Following the same rationale, chitosan has been
combined with other biomaterials because of its similarity with proteoglycans normally
present in native cartilage. The resulting hybrid scaffolds were found to enhance
cartilage tissue formation (Chen et al, 2007; Cui et al, 2003). This evidence provided
the rationale behind our efforts to produce a scaffold that would provide both chemical
(aminopolysaccharide) as well as biophysical (fibrous) lineage-specific cues similar to
those of native cartilage matrix. The mechanisms by which chitosan fibers improve
chondrogenesis over sponges remain speculative but could rely on enhanced cell-cell
and/or cell-matrix interactions. The chondrogenic differentiation of MSCs typically
proceeds through condensation, conventionally achieved by adapting pellet and
micromass cultures. The formation of cell clusters promotes cadherin-mediated cell-
cell interactions. Among these, the N-cadherin and cadherin 11 molecules have been
proposed to play a determinant role in MSCs condensation and subsequent
chondrogenesis (Luo et al, 2005). Although we did not observe a difference in cell
aggregation between groups on SEM and histology, fibrous scaffolds may facilitate
cell-cell interactions over sponges. Indeed, cell-cell interactions depend on cell density
as well as scaffold structure. Scaffold structure can influence cell contacts by its effects
on cell proliferation and migration throughout the matrix. The smaller surface area of
the fibrous scaffolds likely increases the chance for cell-cell interactions by decreasing
the available biomaterial surface per cell. An open structure consisting of loosely
arranged fibers or leached pores can enhance cell diffusion throughout the matrix,
thereby promoting cell-cell interaction. However, this last mechanism is unlikely to
have contributed alone to our results since cell seeding was similar between groups.
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The structure also affects nutrient diffusion within the scaffold (Karande et al,
2004). Fluid flow through the structure is a combination of five important scaffold
parameters: porosity, pore size and distribution, interconnectivity, fenestration size and
distribution, and pore orientation (Lee et al, 2008; Li et al, 2003). Differences in those
characteristics could therefore affect cell-nutrient interaction, possibly resulting in
better chondrogenesis for one scaffold type compared to the other (Lee et al, 2008;
Sasmazel et al, 2008; Yamane et al, 2006). However, improved mass transport within
3-D matrix has been found to impact cell proliferation (Griffon et al, 2006; Mukherjee
et al, 2009). This mechanism is unlikely to have contributed to our results since cell
proliferation was similar between groups. The biophysical cues provided by the local
microstructural environment rely primarily on interactions between the matrix and cell
surface receptors, initiating intracellular signals mediated via cytoskeletal networks
(Mooney et al, 1995; Woods et al, 2007). Interestingly, chondrogenesis was improved
in scaffolds with the smaller available surface area. However, other scaffold
characteristics affect the TGF-β and Hedgehog pathways, known to profoundly
influence chondrogenesis (Chen et al, 2008). A fibrous microstructure simulates more
closely the relative size relationship between cells and the extracellular matrix proteins
contained in cartilage, thereby affecting the interaction with transmembrane integrin
receptors (Moroni et al, 2006). These receptors are known to activate actin-filament
polymerization and promote focal adhesion formation (Discher et al, 2005). Cell
attachment modifies the cytoskeletal network and influences cell signaling and cell
function (Mooney et al, 1995; Woods et al, 2007), but can also be affected by
differences in mechanical properties between fibrous scaffolds and sponges (Engler et
al, 2006; Kong et al, 2005). However, mechanical testing of the scaffolds was not
performed as, under the culture conditions used, the meso- or microenvironments are
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sensed by individual cells, not the representative volume element (or scaffold) (Gibson
et al, 1999). The importance of the cytoskeletal network in chondrogenesis was
recently highlighted in a study where decreased chondrogenesis of MSCs on RGD-
modified hydrogels was reversed by disrupting the F-actin cytoskeleton (Connelly et al,
2008). Integrin stimulation was found to modulate the TGF signaling cascade involving
Smad2 and Smad3 leading to an increase in type II collagen transcription
(Schneiderbauer et al, 2004). We cannot conclude as to the contribution of this
mechanism to our results because cells were embedded in extracellular matrix
preventing our ability to evaluate differences in cytoskeletal organization. Future
studies should be conducted to evaluate the expression of chondrogenic differentiation
promoters in relation to cytoskeletal organization and cytoplasmic extension.
4.3. Effect of the Degree of Deacetylation on Cell Adhesion on Chitosan Scaffolds
The influence of the DD of chitosan on cell attachment remains controversial
and varies between reports and cell types (Fakhry et al, 2004). In several studies,
deacetylation improved the attachment of fibroblasts, Schwann cells, keratinocytes, and
neurons to chitosan films or sponges (Amaral et al, 2007; Chatelet et al, 2001; Freier et
al, 2005; Seda Tigli et al, 2007; Tigli et al, 2008; Wenling et al, 2005). However, in
others, a lower DD of chitosan did not affect the attachment of chondrocytes,
fibroblasts, or osteoblasts (Hamilton et al, 2006; Kuo et al, 2006; Suphasiriroj et al,
2009; Suzuki et al, 2008). These conflicting results may be due to differences in origin,
molecular weight, and/or viscosity of the agents tested (chitosan, chitin, re-acetylated
chitosan) as well as differences in experimental design such as cell population and
serum supplementation (Hamilton et al, 2006; Suphasiriroj et al, 2009). We describe for
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the first time a decreased cell attachment of MSCs on reacetylated chitosan scaffolds
(DD: 4%) compared to chitosan (DD: 92%). The scaffolds were produced from the
same source of chitosan to avoid variation due to characteristics other than DD. Cells
were seeded in medium containing serum, routinely recommended for culture of MSCs.
The positive relationship between adhesion of MSCs and the DD of chitosan scaffolds
could be explained by several possible mechanisms. It was first suspected that the
amine groups of the deacetylated form of chitosan would remain protonated to -NH3+ in
media, resulting in a cationic nature primarily responsible for electrostatic interactions
between protonated amine groups and negatively charged cell surfaces (Chatelet et al,
2001; Suphasiriroj et al, 2009). However, the majority of the ammonium groups
become dissociated and subsequently uncharged when the medium reaches a pH close
to the pKA of chitosan (6.46 to 6.8) (Amaral et al, 2007). This explains why the zeta
potentials of chitosan films were null or slightly positive in neutral medium and not
affected by the DD (Tomihata et al, 1997). The cell adhesion characteristics of the
chitosan may therefore not be directly related to direct cell-matrix interactions but
instead, correlate with the differential adsorption of proteins present in the culture
medium to the biomaterial (Chastain et al, 2006). Although no correlation has yet been
established between the adsorption of type II collagen and the DD of scaffolds, the
mechanism of protein adsorption in media containing serum most likely differs from
that of single protein adsorption in acidic conditions. Chitosan with a high DD may
accelerate cell adhesion after forming polyelectrolyte complexes with serum
components such as heparin, platelet-derived growth factor, laminin, or fibronectin
(Inui et al, 1995; Mori et al, 1997). Chitosan with a higher DD can bind more growth
factors in the serum and protect them from degradation and/or present them to the cells
in an active form (Howling et al, 2001; Mori et al, 1997). This could potentially explain
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the absence of effect of the DD on fibroblast attachment and proliferation found by
Hamilton et al. in serum free media (Hamilton et al, 2006). The DD of chitosan
scaffolds has been shown to impact the final constructs in skeletal tissue engineering
applications. Several studies have reported improved characteristics of the extracellular
matrix produced by chondrocytes (Kuo et al, 2006; Suzuki et al, 2008), or osteoblasts
(Amaral et al, 2007; Suphasiriroj et al, 2009) when these cells were cultured on
chitosan scaffolds of lower DD. These publications justify our attempts to overcome
the poor cell adhesion on chitin and reacetylated chitosan (Chatelet et al, 2001; Freier et
al, 2005; Hamilton et al, 2006). Type II collagen did not improve the overall cell
seeding efficiency of reacetylated chitosan constructs. Even if the cell distribution
appeared more homogeneous in the collagen-coated constructs, the poor adhesion
properties of reacetylated chitosan seem difficult to overcome.
4.4. Effect of the Hyaluronic Acid Coating on Chitosan Scaffolds
HA has been used for clinical management of joint disease. Results of clinical
studies have shown the efficacy of HA (Atamaz et al, 2006). HA interacts with cells
and plays a pivotal role in stimulating chondrocyte metabolism as well as maintaining
cell shape and behavior (Akmal et al, 2005; Kuroki et al, 2002; Lee et al, 2000;
Takeuchi et al, 2006). HA has also been found to induce a 22-fold increase in
proteoglycan synthesis by chondrocytes cultured in a gelatin sponge, presumably via
interactions with CD44 receptors (Goodstone et al, 2004). This evidence provided the
rationale behind our efforts to use HA to coat chitosan scaffold in order to improve
both cell adhesion and cell differentiation. The effects of HA coating have not been
studied on MSCs chondrogenesis, even if chondrogenesis has been described on HA-
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chitosan hybrid scaffolds (Yamane et al, 2005; Yamane et al, 2006). We did not find
evidence that the addition of HA improve MSCs chondrogenesis. It is possible that HA
does not have the same effects on MSCs chondrogenesis than on extracellular matrix
production by chondrocytes; this lack of effect being or not related to CD44 expression
by MSCs. HA may also have eluted from the scaffolds and was therefore removed from
the media during the first change of media limiting its effect on cell differentiation.
Future studies are required to clarify the stability of HA coating on chitosan scaffolds
and the effect of HA on MSCs chondrogenesis.
The addition of HA to the chitosan did not improve MSC attachment to the
scaffolds. CD44 expression by the MSCs may be limited, impeding efficient HA
interaction (Herrera et al, 2007). It is also possible that the coating technique did not
allow strong bonding between the chitosan and the HA leading to rapid elution of the
HA from the scaffolds. The elution of HA from the chitosan is possible because of its
high water solubility, rapid resorption, and short residence time and despite the anionic
behavior of HA complementary to the cationic chitosan (Funakoshi et al, 2005). Fast
and early cell-HA interactions tether cells to the surface and provide the temporal and
spatial framework for slower integrin-mediated interactions to occur (Cohen et al,
2006; Peniche et al, 2007; Tan et al, 2007; Zaidel-Bar et al, 2004; Zimmerman et al,
2002). Slow integrin-mediated adhesion will not have the time to occur if HA elutes
from the scaffold before or during its interaction with the cells. Limiting the elution of
HA from chitosan scaffolds may therefore require modifications of the carboxyl and
hydroxyl groups of HA and/or crosslinking using divinyl sulfone, glycidyl ether, or
dialdehyde (Hahn et al, 2005). The biocompatibility of these modifications must be
considered carefully before clinical application of the resulting scaffolds.
Polyelectrolyte complex multilayer is an alternative process to increase HA stability on
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chitosan without affecting the biocompatibility but it is not feasible for 3-D scaffolds
(Hahn et al, 2005).
4.5. Effect of Type II Collagen Coating on Cell Adhesion on Chitosan Scaffolds
The initial attachment of cells during seeding is a prerequisite for a successful
tissue engineering outcome as it is a decisive factor for cell-matrix and cell-cell
interactions (Mahmood et al, 2004). Considerable attention has recently focused on
chitosan scaffolds but their use has been limited because of their deficient properties for
cell adhesion (Amaral et al, 2007; Griffon et al, 2010; Seda Tigli et al, 2007; Wenling
et al, 2005). Modifying chitosan scaffolds to optimize cell adhesion within the 3-D
matrices is crucial to improve seeding yield and uniformity of cell distribution. Our
results confirm the low seeding efficiency of chitosan scaffolds (48 to 70% with
chondrocytes, 47 to 57% with MSCs) seeded with MSCs. Cells seem to display a
greater affinity for each other than for the surface of chitosan, forming clusters that
contributed to the uneven cell distribution within constructs. Coating chitosan fibers
with type II collagen did not affect the structural properties of the scaffolds but
improved cell adhesion. The structure, wettability and porosity of coated scaffolds were
consistent with previous reports (Griffon et al, 2010; Nettles et al, 2002). This
structural similarity between scaffolds allows direct evaluation of the effect of chemical
composition (collagen coating) on cell seeding (Karande et al, 2004; Malda et al,
2005). The coating did not impact cell viability but increased the cell seeding efficiency
by 41 to 73% in a dose-dependent manner. The seeding efficiency of the collagen
coated scaffold meets the criteria for application in tissue engineering (Vunjak-
Novakovic et al, 1998). Type II collagen coating also improved cell distribution in
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collagen-coated constructs improving attachment to fibers rather than formation of
clusters compared to chitosan constructs. This may help overcome the concern of poor
tissue ingrowth in the center of the scaffolds commonly encountered in tissue
engineering applications (Griffon et al, 2006; Karande et al, 2004). These effects may
be attributed to the presence of binding sites in type II collagen, such as the amino acid
sequences GFOGER and RGD. These binding sites have been found to promote cell
attachment by the integrins α1, α2, α10, and/or α11β1, the discoidin-domain receptors,
and the annexin V receptor (Durr et al, 1993; Freyria et al, 2009; Gigout et al, 2008;
Reid et al, 2000).
In the last study, no difference in cell content was found between PGA and
chitosan constructs. The seeding efficiency for the PGA scaffolds was 40% after two
days of culture. Based on previous studies, we expected that the seeding efficiency of
chitosan would be lower than PGA based on previous studies (Griffon et al, 2005;
Griffon et al, 2006). However, Vunjak-Novakovic et al. obtained a seeding efficiency
of 55% using a similar seeding technique for PGA scaffolds. This percentage actually
represented the combined effects of initial attachment and three days of cell
proliferation (Vunjak-Novakovic et al, 1998). The similar seeding efficiency obtained
on chitosan and PGA is therefore more likely related to a difference in chitosan
properties between studies. The DD correlates with attachment of cells such as
fibroblasts, Schwann cells, keratinocytes, and neurons to chitosan films or sponges
(Amaral et al, 2007; Chatelet et al, 2001; Freier et al, 2005; Seda Tigli et al, 2007; Tigli
et al, 2008; Wenling et al, 2005). A lower molecular weight of the chitosan may also
improve seeding efficiency (Hamilton et al, 2006). The chitosan used in this study had
either a greater DD (92%) compared to the chitosan used in previous studies (85%)
(Griffon et al, 2005; Griffon et al, 2006), or a lower molecular weight (480kDa
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compared to 500 kDa). Difference in media composition between those studies could
also affect cell adhesion due to the differential adsorption of proteins present in the
culture medium to the chitosan (Chastain et al, 2006).
4.6. Effect of Type II Collagen Coating on Chondrogenesis on Chitosan Scaffolds
The adhesion of the cells to the matrix is believed to be a decisive factor for
intracellular signals, influencing subsequent cell-matrix interaction and cell
differentiation (Aydelotte et al, 1988; Mahmood et al, 2004; Reid et al, 2000). The
ability of type II collagen to improve chondrogenic differentiation of MSCs was
therefore tested and we found that type II collagen coating improved the amount and
quality of the ECM present at 21 days in the constructs. The increase in ECM content
likely reflects the greater cell content of the collagen coated constructs since the
GAG/DNA content was greater in the PGA and chitosan constructs. However, for the
collagen coated constructs, the morphological features evaluated by SEM and TEM
were more consistent with normal chondrocytes, the ECM quality assessed by GAG
quantification and immunohistochemistry was improved, and the type II collagen and
aggrecan mRNA expression was increased. These findings suggest an improved
differentiation of MSCs in the type II collagen coated scaffolds. The difference in
chondrogenesis between coated and non-coated constructs is likely due to the
synergistic effect of TFG-β1 and extracellular type II collagen on Smad 2
phosphorylation which has been shown to increase the level of type II collagen mRNA
expression (Schneiderbauer et al, 2004), as well as aggrecan mRNA expression (Qi et
al, 1997; Qi et al, 1998). The MSCs differentiation was affected by the presence, but
not the density, of type II collagen. Integrin stimulation through type II collagen
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interactions may improve chondrogenesis once above a threshold level, as for BMP
signaling (Bandyopadhyay et al, 2006). However, the two collagen densities studied
may also not be different enough to result in distinct cell signaling. Further studies are
required to evaluate if a concentration of type II collagen greater than 22μg/mg can
further improve the chondrogenic properties of chitosan-based scaffolds. Also, we
cannot eliminate the potential influence of improved cell-cell interactions on the
chondrogenic differentiation. In fact, the chondrogenic differentiation of MSCs
typically proceeds through condensation, conventionally achieved by adapting pellet
and micromass cultures. The formation of cell clusters due to increased cell density
promotes cadherin-mediated cell-cell interactions. Among these, the N-cadherin and
cadherin 11 molecules have been proposed to play a determinant role in MSCs
condensation and subsequent chondrogenesis (Luo et al, 2005).
Type X collagen mRNA expression was increased in the chitosan constructs
compared to the PGA. Type X collagen has been associated with chondrocyte
hypertrophy (Harrington et al, 2004; Steinert et al, 2009). Hypertrophy is usually
characterized by an increased cell volume and vacuolization, a production of type X
collagen and alkaline phosphatase, and a concomitant decrease in the synthesis of type
II collagen and aggrecan (Harrington et al, 2004; Steinert et al, 2009). The only change
consistent with hypertrophy for all chitosan constructs is the increased expression of
type X collagen mRNA but quantifications of type X collagen and ALP in the ECM
were not performed. However, the relation between this finding and an increase in
chondrogenic hypertrophy in those constructs seems difficult to establish since marked
vacuolization was observed in the PGA constructs. Furthermore, the use of type X
collagen mRNA as a marker of chondrogenic hypertrophy for MSCs has recently been
questioned (Harrington et al, 2004; Mwale et al, 2006). Further studies should focus on
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the significance of the increase in type X collagen mRNA expression in the chitosan
constructs.
No difference in cell number or quantitative ECM evaluation was found
between the two groups of collagen-coated constructs at 21 days. The cell population in
both coated groups increased by 109% compared with the 48 hour assessment; whereas
the cell number increased by 32% and 15% in the chitosan and PGA constructs,
respectively. The presence of type II collagen seems responsible for an initial
stimulation of the cell proliferation. However, the cell number in the collagen coated
constructs seems to have reached a plateau at 21 days, possibly because of the scaffold
size limitation.
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS
The chemical structure of chitosan had a positive effect on the production of
extracellular matrix by chondrocytes. The replica molding technique was proven to be a
good alternative to fabricate chitosan fibrous scaffolds since the resulting fibers had a
low variability in their cross-sectional widths and the viability and morphologic
appearance of the chondrocytes were comparable or superior to other reports after three
weeks of culture. No major difference was found between chitosan meshes of different
fiber widths (4 to 22 μm range). The fibrous structure of chitosan scaffolds improved
the differentiation of mesenchymal stem cells into chondrocytes, resulting in an
extracellular matrix of better quality compared to sponges.
Cell adhesion on chitosan scaffolds was not improved with the degree of
acetylation of chitosan or by hyaluronic acid coating but was increased by type II
collagen coating. Type II collagen coating also enhanced the chondrogenesis of the
MSCs on chitosan-based scaffolds. These findings encourage the use of fibrous
chitosan scaffolds coated with type II collagen for cartilage tissue engineering
applications and confirm the importance of biomimetic scaffolds for tissue engineering.
The polyglycolic acid mesh tested as a reference in this work did not perform as
well as the chitosan scaffolds. The fragmentation of the polyglycolic acid fibers will
likely further limit the use of polyglycolic acid for in vivo cartilage tissue engineering
studies. Similarly, the decreased properties of reacetylated chitosan for cell adhesion
will also limit its use for tissue engineering.
Limitations remain before direct clinical application of the chitosan fibrous
scaffolds coated with type II collagen to improve treatment of articular cartilage
defects. Firstly, MSCs chondrogenesis should be improved to obtain a construct with
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similar structural and mechanical properties than native cartilage. The limited
knowledge available regarding optimal chondrogenic differentiation impedes the
development of novel strategies for the clinical use of MSCs. To improve MSCs
chondrogenesis, it is important to start be controlling most culture variables and
examining the effects of a specific modification of the culture condition. We used a
standard chondrogenic protocol and the only variable evaluated was the scaffold. Many
unknowns remain concerning proper chondrogenic differentiation and those should be
addressed in future studies, where the scaffold variable should be controlled and other
culture variables such as cell source and growth factor provided should be evaluated.
Secondly, the construct obtained in vitro should integrate with the surrounding tissue
once replaced in vivo. One solution to improve the integration will be the generation of
a biphasic scaffold to mimic the cellular profile of native osteochondral tissue after
culture with multi-potent MSCs. The scaffolds designed in this study should be used to
develop the chondral portion of the construct while a scaffold with an osteogenic
profile should be used to obtain the osteogenic base of the construct. This base may
allow a better integration with the adjacent tissue since articular cartilage does not
integrate well. Finally, in vivo studies will then have to be performed to test the
effectiveness of those constructs in handling biomechanical forces and their ability to
integrate with the adjacent tissue.
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